Unico American (UNAM) 10-K/A 12 Jul 22 2021 FY Annual report (amended) Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2021	May 31, 2022	Jun. 30, 2021
Cover [Abstract]
Entity Registrant Name	UNICO AMERICAN CORPORATION
Entity Central Index Key	0000100716
Document Type	10-K/A
Amendment Flag	true
Entity Voluntary Filers	No
Current Fiscal Year End Date	--12-20
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	No
Document Period End Date	Dec. 31, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Entity Common Stock Shares Outstanding		5,304,863
Entity Public Float			$ 13,916,355
Document Annual Report	true
Document Transition Report	false
Entity File Number	000-03978
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	95-2583928
Entity Address Address Line 1	5230 Las Virgenes Road
Entity Address City Or Town	Calabasas
Entity Address State Or Province	CA
Entity Address Postal Zip Code	91302
City Area Code	818
Icfr Auditor Attestation Flag	false
Auditor Location	Hartford, CT
Auditor Firm Id	688
Local Phone Number	591‑9800
Security 12b Title	Common Stock, No Par Value
Trading Symbol	UNAM
Security Exchange Name	NASDAQ
Entity Interactive Data Current	No
Auditor Name	Marcum LLP
Amendment Description	This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, which was filed with the SEC on July 11, 2021 (the “Original Filing”).  We are filing this Amendment solely for the limited purpose of amending Part II, Item 8 , note 22 to the financial statements on page 92 of the Original Filing to include a tabular presentation of the average annual percentage payout of incurred claims by age, net of reinsurance, as of December 31, 2021 (the “Omitted Disclosure”), which was inadvertently omitted from the Original Filing.  For convenience, we are refiling the entire Annual Report on Form 10-K, as amended, including the Omitted Disclosure, and certifications by our principal executive officer and principal financial officer, which are being filed as Exhibits 31.1, 31.2 and 32.1.  Except as described above, no other information included in the Original Filing is amended or changed by the Amendment. This Amendment does not reflect events occurring after the date of the filing of the Original Filing or modify or update any of the other disclosures contained therein in any way.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Available-for-sale:
Fixed Maturities, At Fair Value (amortized Cost: $71,518,405 At December 31, 2021, And $80,071,280 At December 31, 2020)	$ 72,413,405	$ 83,409,694
Held-to-maturity:
Fixed Maturities, At Amortized Cost (fair Value: $300,000 At December 31, 2021, And $798,000 At December 31, 2020)	300,000	798,000
Equity Securities, At Fair Value (cost: $3,532,026 At December 31, 2021 And $2,548,440 At December 31, 2020)	4,131,153	2,746,706
Short-term Investments, At Fair Value	1,154,750	200,000
Total Investments	77,999,308	87,154,400
Cash, Cash Equivalents, And Restricted Cash (restricted Cash Of $381,942 At December 31, 2021, And $1,210,243 At December 31, 2020)	15,626,651	3,957,980
Accrued Investment Income	369,928	402,046
Receivables, Net	1,204,013	3,321,337
Reinsurance Recoverable:
Paid Losses And Loss Adjustment Expenses	911,566	621,307
Unpaid Losses And Loss Adjustment Expenses	27,116,043	22,253,642
Deferred Policy Acquisition Costs	986,806	3,503,248
Real Estate Held For Sale, Net	0	8,335,017
Property And Equipment, Net	2,154,520	2,038,415
Other assets	502,095	313,363
Total assets	126,870,930	131,900,755
Liabilities
Unpaid Losses And Loss Adjustment Expenses	82,492,674	74,893,509
Unearned Premium	14,331,273	18,188,298
Advance Premium And Premium Deposits	102,846	208,538
Accrued Expenses And Other Liabilities	2,266,237	3,577,450
Total liabilities	99,193,030	96,867,795
Stockholders' Equity
Common Stock, No Par Value - Authorized 10,000,000 Shares; 5,304,863 And 5,304,885 Shares Issued And Outstanding At December 31, 2021 And 2020, Respectively	3,783,346	3,771,767
Accumulated Other Comprehensive Income	944,050	2,637,347
Retained Earnings	22,950,504	28,623,846
Total stockholders' equity	27,677,900	35,032,960
Total liabilities and stockholders' equity	$ 126,870,930	$ 131,900,755

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Consolidated Balance Sheets Parenthetical Abstract
Fixed Maturities, Available For Sale, Amortized Cost	$ 71,218,405	$ 80,071,280
Fixed Maturities, Held To Maturity, Fair Value	300,000	798,000
Equity Securities, Cost	3,532,026	2,548,440
Restricted Cash	$ 381,942	$ 1,210,243
Common Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares Issued	5,304,863	5,304,885
Common Stock, Shares Outstanding	5,304,863	5,304,885

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Revenues
Net Earned Premium	$ 28,429,905	$ 28,168,168
Net Investment Income	1,932,993	1,988,243
Net Realized Investment Gains	259,912	97,771
Net Realized Gain On Real Estate	3,693,858	0
Net Unrealized Investment Gains On Equity Securities	400,862	198,266
Other Income (loss)	(83,043)	32,713
Total insurance company operations	34,634,487	30,485,161
Other Insurance Operations:
Gross Commissions And Fees	1,601,427	1,827,263
Finance Fees Earned	151,920	240,589
Other Income	550	7,098
Total revenues	36,388,384	32,560,111
Expenses
Losses And Loss Adjustment Expenses	25,972,840	34,642,920
Policy Acquisition Costs	5,442,645	4,898,807
Salaries And Employee Benefits	3,850,568	6,364,170
Commissions To Agents/brokers	80,586	95,315
Other Operating Expenses	6,256,079	4,502,414
Total expenses	41,602,718	50,503,626
Loss Before Taxes	(5,214,334)	(17,943,515)
Income Tax Expense	458,917	3,547,598
Net loss	$ (5,673,251)	$ (21,491,113)
Basic
Loss Per Share	$ (1.07)	$ (4.05)
Weighted Average Shares	530,487,200	530,582,900
Diluted
Loss Per Share	$ (1.07)	$ (4.05)
Weighted Average Shares	5,304,872	5,305,829

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Consolidated Statements of Comprehensive Loss
Net Loss	$ (5,673,251)	$ (21,491,113)
Other Changes In Comprehensive Income (loss):
Changes In Unrealized (losses) Gains On Securities Classified As Available-for-sale Arising During The Period, Net Of Income Tax	(1,693,297)	1,454,481
Comprehensive loss	$ (7,366,548)	$ (20,036,632)

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Shares	Accumulated other comprehensive Income (Loss)	Retained Earnings
Balance, Shares at Dec. 31, 2019		5,306,720
Balance, Amount at Dec. 31, 2019	$ 55,080,325	$ 3,772,669	$ 1,182,866	$ 50,124,790
Shares Repurchased, Shares		1,835
Shares Repurchased, Amount	(10,733)	$ (902)	0	(9,831)
Change In Unrealized Gain , Net Of Deferred Income Tax	1,454,481	0	1,454,481	0
Net Loss	(21,491,113)	0	0	(21,491,113)
Stock Based Compensation	0
Balance, Amount at Dec. 31, 2020	35,032,960	$ 3,771,767	2,637,347	28,623,846
Balance, Shares at Dec. 31, 2020		5,304,885
Shares Repurchased, Shares		22
Shares Repurchased, Amount	(101)	$ (10)	0	(91)
Change In Unrealized Gain , Net Of Deferred Income Tax	(1,693,297)	0	(1,693,297)	0
Net Loss	(5,673,251)	0	0	(5,673,251)
Stock Based Compensation	11,589	11,589
Balance, Amount at Dec. 31, 2021	$ 27,677,900	$ 3,783,346	$ 944,050	$ 22,950,504
Balance, Shares at Dec. 31, 2021		5,304,863

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities:
Net Loss	$ (5,673,251)	$ (21,491,113)
Adjustments To Reconcile Net Loss To Net Cash From Operations:
Depreciation And Amortization	569,801	673,895
Bond Amortization, Net	(163,497)	33,072
Stock-based Compensation	11,589	0
Bad Debt Expense	(167,532)	6,451
Allowance For Policy Acquisition Costs	1,409,654	0
Net Realized Investment Gains	(259,912)	(97,771)
Net Realized Gain On Real Estate Sale	(3,693,858)	0
Net Unrealized Investment Gains On Equity Securities	(400,862)	(198,266)
Net Receivables	2,284,856	686,905
Accrued Investment Income	32,118	0
Reinsurance Recoverable	(5,152,660)	(7,463,253)
Deferred Policy Acquisition Costs	1,106,788	116,346
Other Assets	(197,532)	116,942
Unpaid Losses And Loss Adjustment Expenses	7,599,165	19,827,029
Unearned Premiums	(3,857,025)	377,961
Advance Premium And Premium Deposits	(105,692)	(10,545)
Accrued Expenses And Other Liabilities	(1,311,214)	1,447,150
Income Taxes Deferred	450,117	3,538,798
Income Taxes Current	8,800	0
Net Cash Used By Operating Activities	(7,510,147)	(2,436,399)
Cash Flows From Investing Activities:
Purchase Of Fixed Maturity Investments	(26,757,589)	(20,580,448)
Purchase Of Equity Securities	(2,207,722)	(2,548,440)
Proceeds From Maturity Of Fixed Maturity Investments	28,055,016	16,050,870
Proceeds From Sale Or Call Of Fixed Maturity Investments	8,199,898	6,525,408
Proceeds From Sale Of Equity Securities	1,501,095	0
(Purchases) Sales Of Short-term Investments	(954,750)	1,996,815
Proceeds From Sale Of Real Estate Held For Sale	12,028,876	0
Purchase Of Property And Equipment	(685,905)	(820,732)
Net Cash Provided By Investing Activities	19,178,919	623,473
Cash Flows From Financing Activities:
Repurchase Of Common Stock	(101)	(10,733)
Net Cash Used By Financing Activities	(101)	(10,733)
Net Change In Cash And Restricted Cash	11,668,671	(1,823,659)
Cash And Restricted Cash At Beginning Of Period	3,957,980	5,781,639
Cash And Restricted Cash At End Of Period	15,626,651	3,957,980
Supplemental Cash Flow Information
Income Taxes	$ 8,800	$ 8,800

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Summary Of Significant Accounting Policies	NOTE 1 ‑ SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Business Unico American Corporation (the “ Company Unico During the quarter ended September 30, 2021, Unico took actions to cause its subsidiary, Crusader Insurance Company (“Crusader”), to enter into runoff. In connection with its runoff, Crusader began to cease writing new and renewal business and to wind down operations that support the writing of insurance policies. Effective September 30, 2021, Crusader ceased writing any new insurance policies and no longer renews policies after December 8, 2021. Crusader issued notices of non-renewal in accordance with the California Department of Insurance (“ CA DOI AAC Principles of Consolidation The accompanying consolidated financial statements include the accounts of Unico American Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. Basis of Presentation The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“ GAAP Going Concern Supervision Agreement Special Examiner Based on Unico’s current cash, and short‑term investments at December 31, 2021, as well as the other factors described herein, there is substantial doubt that Unico will have sufficient cash to meet its operating and other liquidity requirements when they become due during the next twelve months from the date of issuance of the accompanying consolidated financial statements. Unico needs to improve its consolidated operating results, continue to receive financial support from Crusader, and/or raise substantial additional capital to continue to fund its operations. Unico has taken actions to cause Crusader to enter into runoff and to wind down operations that support the writing of insurance policies. To address its liquidity concerns and meet its capital obligations, Unico has announced a review of strategic alternatives and, with the assistance of a financial advisor, is considering multiple alternatives, including, but not limited to, strategic financing, further scaling back, or eliminating some or all of its remaining business operations, expense reductions, reorganization, merger with another entity, filing for bankruptcy or cessation of operations. There can be no assurances that capital will be available when needed or that, if available, it will be obtained on terms favorable to the Company and its stockholders, particularly in light of the effects that the coronavirus COVID-19 (“ COVID-19” Use of Estimates in the Preparation of the Financial Statements The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these consolidated financial statements relate to losses and loss adjustment expenses. Actual results may differ significantly from the estimates used in preparing the consolidated financial statements. Supervision Agreement Crusader and the CA DOI entered into the Supervision Agreement, dated September 7, 2021, at the request of the CA DOI. The Supervision Agreement was requested by the CA DOI because of the CA DOI’s expressed concerns regarding the financial stability of Crusader and the potential effects on Crusader and Crusader’s California policyholders of any potential bankruptcy of Unico. The Supervision Agreement among other things, provides for the appointment by the CA DOI of a Special Examiner to provide supervision and regulatory oversight of Crusader. The Supervision Agreement imposes limitations on Crusader’s ability to take certain actions without the prior written consent of the CA DOI Commissioner (the “ Commissioner On September 13, 2021, the Special Examiner advised Crusader, through its counsel, that a deficiency existed in certain funds that Unifax is required to maintain, in a fiduciary capacity, for Crusader's benefit. Pursuant to the provisions of California Insurance Code Sections ("CIC") Sections 1733 and 1734, Unifax is required to hold premium payment funds received from policyholders as fiduciary funds in trust maintained for the benefit of Crusader. The Special Examiner informed Crusader that the CA DOI believed that the deficiency in such fiduciary funds was approximately $3,100,000 as of September 13, 2021. As of September 30, 2021, the amount of such deficiency was $2,452,835. In January 2022 Unico, Crusader, and Unifax agreed, with the pre-approval of the Special Examiner, to transfer a computer system, owned by Unico, to Crusader. Unico contributed the computer system at its book value of $1,991,956, to Unifax, and Unifax in turn contributed the computer system to Crusader at its book value of $1,991,956 as a direct reduction in the amount due to Crusader which resulted in a dollar-for-dollar reduction in the premium trust deficiency. The amount of such deficiency was $275,901 as of March 31, 2022, and $432,900 as of May 31, 2022. Independent Investigation The Audit Committee of Unico’s Board of Directors retained independent outside counsel, who in turn engaged forensic accountants to work at their direction, to conduct an independent investigation and provide legal advice to the Audit Committee (the “ Independent Investigation Investments The Company’s fixed maturity investments are classified either as held-to-maturity or available-for-sale. Available-for-sale fixed maturity investments and are stated at fair value and held-to-maturity securities are stated at amortized cost. Although part of the Company's investments is classified as available‑for‑sale and the Company may sell investment securities from time to time in response to cash flow requirements, economic, regulatory, and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity, its investment guidelines place primary emphasis on buying and holding high‑quality investments to maturity. Short‑term investments are carried at cost, which approximates fair value. Equity securities are reported at fair value. The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. The unrealized gains or losses from fixed maturities are reported as “Accumulated other comprehensive income (loss),” which is a separate component of stockholders’ equity, net of any deferred tax effect. The net unrealized investment gains on equity securities are reported in the Consolidated Statements of Operations. When a decline in the value of a fixed maturity is considered other-than-temporary, a loss is recognized in the Consolidated Statements of Operations. Realized gains and losses are included in the Consolidated Statements of Operations based on the specific identification method. The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether it is more likely than not that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes, or the credit quality of the underlying security. If a security meets this criteria, the security's decline in fair value is considered other than temporary and is recorded as a net realized investment loss in the Consolidated Statements of Operations based on the specific identification method. There were no realized investments gains (losses) from other than temporary impairments for any of the periods presented in the accompanying Consolidated Statements of Operations. For each fixed income security that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates the credit loss component of the impairment, if any, from the amount related to all other factors and reports the credit loss component in net realized investment gains (losses). Short‑term investments include U.S. Treasury bills, certificates of deposit, and commercial paper that are all highly rated and have initial maturities between three and twelve months. Fair Value of Financial Instruments The Company employs a fair value hierarchy that prioritizes the inputs for valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs to the valuation techniques. (See Note 5.) The Company has used the following methods and assumptions in estimating its fair value disclosures for instruments carried at fair value: · Available-for-sale fixed maturity securities, equity securities, and short-term investments – Fair values are obtained from widely accepted third party vendors. · Cash, cash equivalents, and restricted cash – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. · Long-term certificates of deposit – The carrying amounts reported in the Consolidated Balance Sheets for these instruments are at amortized cost which approximates their fair value. · Receivables, net – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. · Accrued expenses and other liabilities – The carrying amounts reported in the Consolidated Balance Sheets approximate the fair values given the short-term nature of these instruments. Property and Equipment All property and equipment held for use is stated at cost less accumulated depreciation and amortization on the Consolidated Balance Sheets. Depreciation through the February 12, 2021 sale date on Crusader’s, previously owned building, located at 26050 Mureau Road, Calabasas, California, was computed using the straight-line method over 39 years. Improvements to the building structure were amortized over the useful life of the improvements. Depreciation on furniture, fixtures and equipment in the Calabasas building was computed using the straight-line method over 3 to 15 years. Amortization of tenant improvements in the Calabasas building was being computed using the shorter of the useful life of the tenant improvements or the remaining years of the lease. Refer to Note 6 regarding the sale of the building. Income Taxes The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and AAC are allocated taxes or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2018 and California state income tax authorities for tax returns filed starting at taxable year 2017. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states that Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. The provision for federal income taxes is computed on the basis of income as reported for financial reporting purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Income tax expense provisions increase or decrease in the same period in which a change in tax rates is enacted. At each balance sheet date, management assesses the need to establish a valuation allowance that reduces deferred tax assets when it is more-likely-than-not that any portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate character within the carryback and carryforward periods available under the tax law. Management considers the reversal of deferred tax liabilities, projected future taxable income of an appropriate nature and tax-planning strategies when making this assessment. In light of the net losses that were generated in recent years, as of December 31, 2021, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $11,939,459 that, in management’s judgment, are not more-likely-than-not to be realized. As of December 31, 2020, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses and other temporary differences in the amount of $10,557,080. Earnings Per Share Basic earnings per share exclude the impact of common share equivalents and are based upon the weighted average common shares outstanding. Diluted earnings per share utilize the average market price per share when applying the treasury stock method in determining common share dilution. When outstanding stock options are dilutive, they are treated as common share equivalents for purposes of computing diluted earnings per share and represent the difference between basic and diluted weighted average shares outstanding. In loss periods, the options are excluded from the calculation of diluted earnings per share, as the inclusion of such options would have an anti-dilutive effect. Revenue Recognition a. General Agency Operations Commissions from sales of health insurance are earned and recognized in income based on the satisfaction of a single performance obligation. Marketing, selling, billing, collecting, and administering health insurance policies are a series of distinct services combined as one performance obligation, which is recognized in income monthly over the policy period. Premiums are collected upon the initial sale of health insurance policies and then monthly upon each subsequent periodic payment. As a result, there are limited accounts receivable. Policy fee income is recognized on a pro-rata basis over the terms of the policies. b. Insurance Company Operation Premium is earned on a pro‑rata basis over the terms of the policies. Premium applicable to the unexpired terms of policies in force are recorded as unearned premium. c. Insurance Premium Financing Operations Premium finance interest may be charged to policyholders who choose to finance insurance premium. Interest is charged at rates that vary with the amount of premium financed. Premium finance interest, if any, is recognized using a method that approximates the interest (actuarial) method. Other charges and fees earned include late fees, returned check fees and payment processing fees that are earned when recorded. Losses and Loss Adjustment Expenses The liability for unpaid losses and loss adjustment expenses is based upon the accumulation of individual case estimates for losses reported prior to the close of the accounting period plus estimates based on experience and industry data for development of case estimates and for incurred but unreported losses and loss adjustment expenses. There is a high level of uncertainty inherent in the evaluation of the required loss and loss adjustment expense reserves for Crusader. The long-tailed nature of liability claims, and the volatility of jury awards exacerbate that uncertainty. Crusader records loss and loss adjustment expense reserves at each balance sheet date based upon management’s best estimate of the ultimate payments that it anticipates will be made to settle all losses incurred and related expenses incurred as of that date for both reported and unreported losses. The ultimate cost of claims is dependent upon future events, the outcomes of which are affected by many factors. Crusader’s claim reserving procedures and settlement philosophy, current and perceived social and economic inflation, current and future court rulings and jury attitudes, improvements in medical technology, and many other economic, scientific, legal, political, and social factors all can have significant effects on the ultimate costs of claims. Changes in Company operations and management philosophy also may cause actual developments to vary from the past. Since the emergence and disposition of claims are subject to uncertainties, the net amounts that will ultimately be paid to settle claims may vary significantly from the estimated amounts provided for in the accompanying consolidated financial statements. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Management believes that the aggregate reserves for losses and loss adjustment expenses are reasonable and adequate to cover the cost of claims, both reported and unreported. The Company applies judgment in determining estimates for reserves associated with anticipated recoveries of salvage and subrogation on paid losses and loss adjustment expenses based on its historic salvage and subrogation recovery success pattern. Restricted Funds Note 1 to the Company’s historical annual audited financial statements (“ Note 1 Premium Trust Account”); Restricted funds are as follows: Year ended December 31 2021 2020 (Revised) Premium trust funds (1)(2) $ 381,942 $ 1,210,243 Assigned to state agencies (3) 500,000 998,000 Funds held as collateral (4) 8,162,053 787,653 Total restricted funds $ 9,043,995 $ 2,995,896 (1) The Company is required by law to segregate from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. As disclosed in further detail in Note 1 above under “Supervision Agreement” and “Independent Investigation,” Unifax did not comply with the requirements of the California Insurance Code to hold such funds in separate accounts or segregate such funds in accordance with the CIC. (2) At December 31, 2020, there was a deficiency (the “Premium Trust Account Deficiency”) in the amount of funds required to be held in trust by Unifax for the benefit of Crusader. The amount of the Premium Trust Account Deficiency was $1,595,135 at December 31, 2020. The amount of the Premium Trust Account Deficiency was $2,172,968 as of December 31, 2021. (3) $300,000 and $798,000 included in fixed maturity investments as of December 31, 2021 and 2020, respectively, and $200,000 included in short-term investments as of December 31, 2021 and 2020, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. (4) Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. Deferred Policy Acquisition Costs Policy acquisition costs consist of commissions, premium taxes, inspection fees, and certain other underwriting costs, which are related to the successful production of Crusader insurance policies. Policy acquisition costs that are eligible for deferral are deferred and amortized as the related premium is earned and are limited to their estimated realizable value based on the related unearned premium plus investment income less anticipated losses and loss adjustment expenses. Ceding commission applicable to the unexpired terms of policies in force is recorded as unearned ceding commission, which is included in deferred policy acquisition costs. Reinsurance Crusader employs reinsurance to provide greater diversification of business allowing management to control exposure to potential losses arising from large risks by reinsuring certain levels of risk in various areas of exposure, to reduce the loss that may arise from catastrophes, and to provide additional capacity for growth. Prepaid reinsurance premium and reinsurance receivables are reported as assets and represent ceded unearned premium and reinsurance recoverable on both paid and unpaid losses and loss adjustment expenses, respectively. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured policies. Crusader evaluates each of its ceded reinsurance contracts at its inception to determine if there is sufficient risk transfer to allow the contract to be accounted for as reinsurance under current accounting literature. As of December 31, 2021, and 2020, all such ceded contracts are accounted for as risk transfer reinsurance. Crusader evaluates and monitors the financial condition of its reinsurers and factors such as collection periods, disputes, applicable coverage defenses and other factors to assess the need for any allowance against anticipated reinsurance recoveries. No such allowance was considered necessary at December 31, 2021 or 2020. Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows: Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2021 2020 Renaissance Reinsurance U.S. Inc. A+ $ 14,339,203 $ 11,906,416 Hannover Ruck SE A+ 13,433,710 10,673,173 TOA Reinsurance Company of America A 255,521 295,188 Other A (825 ) 172 Total $ 28,027,609 $ 22,874,949 (1) A.M. Best ratings are as of December 31, 2021. Concentration of Risks 100% and 99.9% respectively of Crusader’s gross written premium was derived from California during the years ended December 31, 2021 and 2020. In 2021, approximately 26% and 58% of the $732,852 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. In 2020, approximately 30% and 56% of the $727,515 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. Stock-Based Compensation Share-based compensation expense for all share-based payment awards is based on the grant-date fair value estimated in accordance with the provisions of ASC Topic 718, “Compensation - Stock Compensation” using the modified prospective transition method. Recently adopted standards In December of 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ ASU 2019-12 Standards not yet adopted In June 2016, the FASB issued Accounting Standards Update No. ASU 2016-13, Measurement of Credit Losses on Financial Instruments, (“ ASU 2016-13 In November 2019, the FASB issued Accounting Standards Update No. 2019-10, Financial Instruments – Credit Losses, Derivatives and Hedging, and Leases, (“ ASU 2019-10

Cash, Restricted Cash and Cash

Cash, Restricted Cash and Cash Equivalents	12 Months Ended
	Dec. 31, 2021
Cash, Restricted Cash and Cash Equivalents
CASH, RESTRICTED CASH AND CASH EQUIVALENTS	NOTE 2 – CASH, RESTRICTED CASH AND CASH EQUIVALENTS The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets to the amounts shown in the Consolidated Statements of Cash Flows: December 31 2021 2020 (Revised) Cash and Cash Equivalents $ 15,244,709 $ 2,747,737 Restricted Cash 381,942 1,210,243 Total $ 15,626,651 $ 3,957,980 As of December 31, 2021, and 2020, cash and restricted cash included custodial trust, bank money market accounts, and a bank savings account. Any financial instruments that are readily convertible into known amounts of cash or are so near their maturity that they present an insignificant interest rate risk are considered cash equivalents. Any certificate of deposit which matures in three months or less from the reporting date is considered a cash equivalent.

Advance Premium and Premium Dep

Advance Premium and Premium Deposits	12 Months Ended
	Dec. 31, 2021
Advance Premium and Premium Deposits
Advance Premium And Premium Deposits	NOTE 3 – ADVANCE PREMIUM AND PREMIUM DEPOSITS The insurance company operation records an advance premium liability that represents the deposits on written premium on policies that have been submitted to the Company and are bound, billed, and recorded prior to their effective date of coverage. The advance premium is not included in written premium or in the liability for unearned premium. Some of the Company’s health and life programs require payments of premium prior to the effective date of coverage; and, accordingly, invoices are sent out as early as two months prior to the coverage effective date. Insurance premium received for coverage months effective after the balance sheet date are recorded as advance premium.

Investments

Investments	12 Months Ended
	Dec. 31, 2021
Investments:
Investments	NOTE 4 – INVESTMENTS A summary of investment income (net of investment expenses), net realized gains, realized gain on real estate sale, and net unrealized investment gains on equity securities is as follows: December 31 2021 2020 Investment income: Fixed maturities $ 1,920,624 $ 2,068,592 Equity securities 90,596 28,727 Short-term investments and cash equivalents 2,660 24,603 Gross investment income 2,013,880 2,121,922 Less investment expenses (80,887 ) (133,679 ) Net investment income 1,932,993 1,988,243 Net realized investment gains 259,912 97,771 Net realized gain on sale of real estate 3,693,858 - Net unrealized investment gains on equity securities 400,862 198,266 Net investment income, realized investment gains, realized gains on real estate sale and unrealized investment gains $ 6,287,625 $ 2,284,280 The amortized cost, estimated fair value and weighted average yield of fixed maturity investments by contractual maturity are as follows: Maturities by Year at December 31, 2021 Amortized Cost Fair Value Weighted Average Yield Due in one year $ 15,758,755 $ 15,875,423 2.21 % Due after one year through five years 19,349,200 19,681,599 1.80 % Due after five years through ten years 19,335,034 19,832,093 2.39 % Due after ten years and beyond 17,075,416 17,324,290 2.35 % Total $ 71,518,405 $ 72,713,405 2.18 % Maturities by Year at December 31, 2020 Amortized Cost Fair Value Weighted Average Yield Due in one year $ 11,064,202 $ 11,169,232 2.57 % Due after one year through five years 30,090,910 31,260,694 2.59 % Due after five years through ten years 18,476,051 19,806,444 2.51 % Due after ten years and beyond 21,238,117 21,971,324 2.63 % Total $ 80,869,280 $ 84,207,694 2.58 % Expected maturities will differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. The weighted average maturity of the Company’s investments was approximately 6.7 years as of December 31, 2021, and 8.0 years as of December 31, 2020. The amortized cost and estimated fair values of investments in fixed maturities by category are as follows: Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value December 31, 2021 Available-for-sale fixed maturities: U.S. Treasury securities $ 6,278,764 $ 67,516 $ (36,475 ) $ 6,309,805 Corporate securities 44,370,193 1,076,288 (196,508 ) 45,249,973 Agency mortgage-backed securities 20,569,448 352,466 (68,287 ) 20,853,627 Held-to-maturity fixed maturities: Certificates of deposit 300,000 - - 300,000 Total fixed maturities $ 71,518,405 $ 1,496,270 $ (301,270 ) $ 72,713,405 December 31, 2020 Available-for-sale fixed maturities: U.S. Treasury securities $ 10,596,808 $ 235,373 $ - $ 10,832,181 Corporate securities 44,159,926 2,347,826 (55,847 ) 46,451,905 Agency mortgage-backed securities 25,314,546 833,336 (22,274 ) 26,125,608 Held-to-maturity fixed maturities: Certificates of deposit 798,000 - - 798,000 Total fixed maturities $ 80,869,280 $ 3,416,535 $ (78,121 ) $ 84,207,694 As of December 31, 2021, six securities were held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of those securities was $8,243,758 and $8,162,053 on December 31, 2021, respectively. As of December 31, 2020, one corporate security, included in available-for-sale fixed maturities, was held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of that security was $824,500 and $787,653 on December 31, 2020, respectively. A summary of the unrealized gains (losses) on investments carried at fair value and the applicable deferred federal income taxes is as follows: Year ended December 31 2021 2020 Gross unrealized gains of fixed maturities $ 1,496,270 $ 3,416,535 Gross unrealized losses of fixed maturities (301,270 ) (78,121 ) Net unrealized gains on investments 1,195,000 3,338,414 Deferred federal tax expense (250,950 ) (701,067 ) Net unrealized gains, net of deferred income taxes $ 944,050 $ 2,637,347 A summary of estimated fair value, gross unrealized losses, and number of securities in a gross unrealized loss position by the length of time in which the securities have continually been in that position is shown below: Less than 12 Months 12 Months or Longer Estimated Fair Value Gross Unrealized Losses Number of Securities Estimated Fair Value Gross Unrealized Losses Number of Securities December 31, 2021 U.S. Treasury securities $ 481,875 $ (15,785 ) 1 $ 476,016 $ (20,690 ) 1 Corporate securities 13,152,240 (128,502 ) 15 1,179,235 (68,006 ) 1 Agency mortgage-backed securities 5,086,187 (43,019 ) 8 471,479 (25,268 ) 1 Total debt securities 18,720,302 (187,306 ) 24 2,126,730 (113,964 ) 3 Equity securities 665,100 (55,156 ) 18 76,454 (4,703 ) 3 Total $ 19,385,402 $ (242,462 ) 42 $ 2,203,184 $ (118,667 ) 6 Less than 12 Months 12 Months or Longer Estimated Fair Value Gross Unrealized Losses Number of Securities Estimated Fair Value Gross Unrealized Losses Number of Securities December 31, 2020 U.S. Treasury securities $ - $ - - $ - $ - - Corporate securities 2,101,986 (55,847 ) 2 - - - Agency mortgage-backed securities 3,223,329 (22,274 ) 12 - - - Total debt securities 5,325,315 (78,121 ) 14 - - - Equity securities 723,346 (37,357 ) 25 - - - Total $ 6,048,661 $ (115,478 ) 39 $ - $ - - The Company monitors its investments closely. If an unrealized loss is determined to be other-than-temporary, it is written off as a realized loss through the Consolidated Statements of Operations. The Company’s methodology of assessing other-than-temporary impairments is based on security-specific analysis as of the balance sheet date and considers various factors including the length of time to maturity and the extent to which the fair value has been less than the cost, the financial condition, and the near-term prospects of the issuer, and whether the debtor is current on its contractually obligated interest and principal payments. The unrealized losses as of December 31, 2021, and December 31, 2020, were determined to be temporary. Although the Company does not intend to sell its fixed maturity investments prior to maturity, the Company may sell investment securities from time to time in response to cash flow requirements, economic, regulatory, and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity. The fixed maturity securities previously held by the Company were sold and called prior to maturity as follows: December 31 December 31 2021 2020 Fixed maturities securities sold Number of securities sold 3 15 Amortized cost of sold securities $ 2,194,103 $ 5,529,470 Realized gains on sales $ 710 $ 52,053 Fixed maturities securities called Number of securities called 10 4 Amortized cost of called securities $ 7,167,178 $ 2,449,503 Realized (losses) gains on calls $ (17,758 ) $ 497 The unrealized gains or losses from fixed maturities are reported as “Accumulated other comprehensive income or loss,” which is a separate component of stockholders’ equity, net of any deferred tax effect. The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. A summary of equity securities is shown below: December 31 December 31 2021 2020 Cost $ 3,532,026 $ 2,548,440 Unrealized gain 599,127 198,266 Fair market value of equity securities $ 4,131,153 $ 2,746,706 The Company’s investment in fixed maturity securities, held-to-maturity, certificates of deposit included $300,000 and $798,000 of brokered certificates of deposit as of December 31, 2021 and 2020, respectively. All of the Company’s certificates of deposit are within the Federal Deposit Insurance Corporation (“FDIC”) insured permissible limits. Due to the nature of the Company’s business, certain bank accounts may exceed FDIC insured permissible limits. The following securities from three different banks represent statutory deposits that are assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in the state of Nevada. Year ended December 31 2021 2020 Certificates of deposit $ 300,000 $ 200,000 Short-term investments 200,000 200,000 Total state held deposits $ 500,000 $ 400,000 All the Company’s brokered and non-brokered certificates of deposit are within the FDIC insured permissible limits. Due to the nature of the Company’s business, certain bank accounts may exceed FDIC insured permissible limits. Short‑term investments have an initial maturity of one year or less and consist of the following: Year ended December 31 2021 2020 Short term bonds 954,750 - Certificates of deposit 200,000 200,000 Total short-term investments $ 1,154,750 $ 200,000

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2021
Fair Value of Financial Instruments
Fair Value Of Financial Instruments	NOTE 5 – FAIR VALUE OF FINANCIAL INSTRUMENTS In determining the fair value of its financial instruments, the Company employs a fair value hierarchy that prioritizes the inputs for the valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs for the valuation techniques as follows: Level 1 – Financial assets and financial liabilities whose values are based on unadjusted quoted prices in active markets for identical assets or liabilities as of the reporting date. Level 2 – Financial assets and financial liabilities whose values are based on quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in non-active markets; or valuation models whose inputs are observable, directly, or indirectly, for substantially the full term of the asset or liability as of the reporting date. Level 3 – Financial assets and financial liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect the Company’s estimates of the assumptions that market participants would use in valuing the financial assets and financial liabilities as of the reporting date. The hierarchy gives the highest priority to Level 1 inputs and the lowest priority to Level 3 inputs. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fair value hierarchy level within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. Thus, a Level 3 fair value measurement may include inputs that are observable (Level 1 or Level 2) or unobservable (Level 3). The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. The following table presents information about the Company’s financial instruments and their estimated fair values, which are measured on a recurring basis, allocated among the three levels within the fair value hierarchy as of December 31, 2021 and 2020: Level 1 Level 2 Level 3 Total December 31, 2021 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 6,309,805 $ - $ - $ 6,309,805 Corporate securities - 45,249,973 - 45,249,973 Agency mortgage-backed securities - 20,853,627 - 20,853,627 Held-to-maturity securities Certificates of deposits - 300,000 - 300,000 Equity securities 4,131,153 - - 4,131,153 Short-term investments 1,154,750 - - 1,154,750 Total financial instruments at fair value $ 11,595,708 $ 66,403,600 $ - $ 77,999,308 December 31, 2020 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 10,832,181 $ - $ - $ 10,832,181 Corporate securities - 46,451,905 - 46,451,905 Agency mortgage-backed securities - 26,125,608 - 26,125,608 Held-to-maturity securities Certificates of deposits - 798,000 - 798,000 Equity securities 2,746,706 - - 2,746,706 Short-term investments 200,000 - - 200,000 Total financial instruments at fair value $ 13,778,887 $ 73,375,513 $ - $ 87,154,400 Fair value measurements are not adjusted for transaction costs. The Company recognizes transfers between levels at either the actual date of the event or a change in circumstances that caused the transfer. The Company did not have any transfers between Levels 1, 2 and 3 of the fair value hierarchy during the years ended December 31, 2021 and 2020. The spread of the ongoing COVID-19 pandemic and other economic uncertainties which have arisen which are likely to impact the fair value of investments. While the Company does not believe it is exposed to substantial risk from coronavirus-related claims under the insurance policies written by Crusader, it is likely that the fair value of its investment portfolio will be adversely affected by the volatility in the capital market. The financial impact of these uncertainties is unknown at this time.

Real Estate Held for Sale, Net

Real Estate Held for Sale, Net and Property and Equipment, Net	12 Months Ended
	Dec. 31, 2021
Real Estate Held for Sale, Net and Property and Equipment, Net
Real Estate Held For Sale, Net And Property And Equipment, Net	NOTE 6 – REAL ESTATE HELD FOR SALE, NET AND PROPERTY AND EQUIPMENT, NET Property and equipment consist of the following: Year ended December 31 2021 2020 Real estate held for sale, located in Calabasas, California $ - $ 10,202,676 Accumulated depreciation and amortization - (1,867,659 ) Real estate held for sale, net $ - $ 8,335,017 Year ended December 31 2021 2020 Furniture, fixtures, equipment 2,316,885 2,191,411 Computer software 466,892 467,275 Accumulated depreciation and amortization (2,983,418 ) (2,423,617 ) Computer software under development 2,354,161 1,803,346 Property and equipment, net $ 2,154,520 $ 2,038,415 On February 12, 2021, the Company, through Crusader, completed the sale of the Company’s headquarters at 26050 Mureau Road, Calabasas, California 91302 (the “Calabasas Building”), for $12,695,000 netting proceeds of $12,028,876 (the “Sale”) to Mureau Road, LLC (“Mureau Road”), a subsidiary of Alliant Capital, Ltd. (“Alliant”). Mureau Road and Alliant do not have any material relationship with the Company or its subsidiaries, other than through the Sale and the Lease (as defined below) transactions. The Company recognized a gain of $3,693,858 on the sale of the Calabasas Building. On February 12, 2021, the Standard-Multi Tenant Office Lease – Net, dated January 28, 2021 (the “Lease”), by and between Crusader and Mureau Road became effective in connection with the completion of the Sale. The Company has agreed to a lease, which expired on January 31, 2022, with Alliant for the second floor of the Calabasas Building with an initial base rent of approximately $56,963 per month, where the Company will continue to operate its corporate headquarters. Through the date of the real estate listing, depreciation on the Calabasas Building, owned by Crusader, is computed using the straight-line method over 39 years. Depreciation on furniture, fixtures, and equipment in the Calabasas Building is computed using the straight-line method over 3 to 15 years. Amortization of leasehold improvements in the Calabasas Building is being computed using the shorter of the useful life of the leasehold improvements or the remaining years of the lease. Depreciation and amortization expense on all property and equipment for the years ended December 31, 2021 and 2020 were $569,801 and $673,895, respectively. For the years ended December 31, 2021 and 2020, the Calabasas Building has generated rental revenue from non-affiliated tenants in the amount of $13,806 and $150,319 and incurred operating expenses in the amount of $235,827 and $677,930, which included depreciation, respectively. These amounts are included in “Other income” from insurance company operations and other operating expenses, respectively, in the Company’s Consolidated Statements of Operations. The Company capitalizes certain computer software costs purchased from outside vendors for internal use or incurred internally to upgrade the existing systems. These costs also include configuration and customization activities, coding, testing, and installation. Training costs and maintenance are expensed as incurred, while upgrade and enhancements are capitalized if it is probable that such expenditure will result in additional functionality. The capitalized costs are not depreciated until the software is placed into production. In 2018, the Company determined it needed to upgrade or replace its legacy IT system, which it opted to upgrade because the cost was substantially less. The upgrade was completed in first quarter of 2021 at a cost of approximately $1,500,000, excluding costs of Unico’s employees involved in the upgrade, due to unexpected technical challenges. The Company started depreciating the associated capitalized costs, including the costs of Unico’s employees involved in the upgrade, during the second quarter of 2021.

Receivables, Net

Receivables, Net	12 Months Ended
	Dec. 31, 2021
Receivables, Net
Premiums, Commissions And Notes Receivable, Net	NOTE 7 – RECEIVABLES, NET Receivables, net, include premium, commissions and notes receivable and are as follows: December 31 2021 2020 Premium and commission receivable $ 672,284 $ 2,476,679 Premium finance notes receivable 755,691 2,036,960 Total premium and notes receivable 1,427,975 4,513,639 Allowance for doubtful accounts (223,962 ) (1,192,302 ) Receivables, net $ 1,204,013 $ 3,321,337 Premium receivable and premium finance notes receivables are substantially secured by unearned premiums and funds held as security for performance. Premium finance notes receivable represents the balance due to AAC, the Company's premium finance subsidiary, from policyholders who elected to finance their premium over a nine-month term. These notes are net of unearned finance charges and credit loss reserves. Bad debt recoveries were $167,532, related to previously written off balances, and bad debt expense was $6,451 for the years ended December 31, 2021 and 2020, respectively.

Unpaid Losses and Loss Adjustme

Unpaid Losses and Loss Adjustment Expenses	12 Months Ended
	Dec. 31, 2021
Unpaid Losses and Loss Adjustment Expenses
Unpaid Losses And Loss Adjustment Expenses	NOTE 8 – UNPAID LOSSES AND LOSS ADJUSTMENT EXPENSES Crusader’s loss and loss adjustment expense case and incurred but not reported (“IBNR”) reserves are as follows: December 31 2021 2020 Gross reserves: Case reserves $ 29,293,117 $ 26,363,695 IBNR reserves 53,199,557 48,529,814 Total gross reserves $ 82,492,674 $ 74,893,509 Reserves net of reinsurance: Case reserves $ 23,057,464 $ 21,027,703 IBNR reserves 32,319,167 31,612,164 Total net reserves $ 55,376,631 $ 52,639,867 Reserves for losses and loss adjustment expenses before reinsurance for each of Crusader’s lines of business are as follows: Year ended December 31 Line of Business 2021 2020 CMP $ 81,303,803 98.5 % $ 73,545,181 98.2 % Other liability 1,122,823 1.4 % 1,283,174 1.7 % Other 66,048 0.1 % 65,154 0.1 % Total $ 82,492,674 100.0 % $ 74,893,509 100.0 % The Company‘s consolidated financial statements include estimated reserves for unpaid losses and related loss adjustment expenses of the insurance company operation. Crusader sets loss and loss adjustment expense reserves at each balance sheet date based upon management’s best estimate of the ultimate payments that it anticipates will be made to settle all losses incurred and all related loss adjustment expenses incurred as of that date for both reported and unreported claims. The following table provides an analysis of the roll forward of Crusader’s loss and loss adjustment expense reserves, including a reconciliation of the ending balance sheet liability for the periods indicated: Year ended December 31 2021 2020 Reserve for unpaid losses and loss adjustment expenses at beginning of year – net of reinsurance $ 52,639,867 $ 40,340,625 Incurred losses and loss adjustment expenses: Provision for insured events of current year 26,097,435 26,683,872 Provision for insured events of prior years (124,595 ) 7,959,048 Total incurred losses and loss adjustment expenses 25,972,840 34,642,920 Payments: Losses and loss adjustment expenses attributable to insured events of the current year 8,007,546 8,285,021 Losses and loss adjustment expenses attributable to insured events of prior years 15,228,530 14,058,657 Total payments 23,236,076 22,343,678 Reserve for unpaid losses and loss adjustment expenses at end of year – net of reinsurance 55,376,631 52,639,867 Reinsurance recoverable on unpaid losses and loss adjustment expenses at end of year 27,116,043 22,253,642 Reserve for unpaid losses and loss adjustment expenses at end of year per balance sheet, gross of reinsurance $ 82,492,674 $ 74,893,509 The $124,595 favorable development in 2021 for insured events of prior years for the year ended December 31, 2021, was an improvement compared to the $7,959,048 adverse development of insured events of prior year for the year ended December 31, 2020, due primarily to increases during the year ended December 31, 2020, in 2018 and 2019 accident year IBNR reserves associated with the Apartments & Commercial Buildings and Transportation Business. The 2020 increases in IBNR were due to higher actuarially developed ultimate incurred losses and loss adjustment expenses primarily as a result of elevated expected claims severity. At each review period, actual claims costs that emerge are compared with the claims costs that were expected to emerge during that development period. Sometimes the previous claims costs estimate prove to have been too high; sometimes they prove to have been too low. The fluctuation in development of insured events of prior years’ underscores the inherent uncertainty in insurance claims costs. Management reviews claims costs that appear to be different from the historical claims costs to determine whether those differences are a normal part of the process or an indication that a change in reserve assumptions is appropriate. Management concluded that the differences noted above are differences between actual and expected claims costs that emerge from time to time, particularly in an insurer the size of Crusader. The following table presents loss development information by accident year, including cumulative incurred and paid losses and allocated loss adjustment expenses (“ALAE”), net of reinsurance, as well as cumulative claim frequency and the total of incurred but not reported liabilities plus expected development on reported claims as of December 31, 2021: Accident Year Cumulative Incurred Cumulative Paid Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims Cumulative Number of Reported Claims 2012 18,353,966 18,355,881 - 967 2013 22,852,457 22,849,314 (2 ) 850 2014 17,965,556 17,817,189 (108,710 ) 760 2015 25,332,806 23,197,570 (525,502 ) 749 2016 27,006,706 24,528,218 (1,584,393 ) 808 2017 26,103,135 21,188,239 (2,301,034 ) 825 2018 19,179,716 13,750,695 (3,465,021 ) 614 2019 18,723,515 10,898,586 (5,558,880 ) 648 2020 22,611,110 9,769,654 (6,518,530 ) 771 2021 23,198,334 5,027,785 (11,452,987 ) 626 Total $ 221,327,301 $ 167,383,131 $ (31,515,059 ) The following table reconciles the above cumulative incurred and paid data to Crusader’s loss and loss adjustment expense reserves: Year ended December 31 2021 2020 Cumulative incurred losses and ALAE $ 221,327,301 $ 218,410,701 Less cumulative paid losses and ALAE (167,383,131 ) (167,214,395 ) Reserve for unpaid losses and ALAE (latest 10 accident years) 53,944,170 51,196,306 Reserves for unpaid losses and ALAE (beyond latest 10 accident years) 68,604 79,703 Reserves for unpaid unallocated loss adjustment expenses 1,363,857 1,363,858 Reserve for unpaid losses and loss adjustment expenses, net of reinsurance 55,376,631 52,639,867 Reinsurance recoverable on unpaid losses and loss adjustment expenses 27,116,043 22,253,642 Reserve for unpaid losses and loss adjustment expenses, gross of reinsurance $ 82,492,674 $ 74,893,509 Crusader’s liability for unpaid loss and loss adjustment expense reserves consists of case reserves and reserves for IBNR claims. Case reserves are established by claims personnel based on a review of the facts known at the time the claim is reported and are subsequently revised as more information about a claim becomes known. IBNR is estimated using various actuarial methods and techniques and includes (1) reserves for losses and loss adjustment expenses on claims that have occurred but for which claims have not yet been reported to Crusader, and (2) a provision for expected future development on case reserves for information not currently known. At the end of each fiscal quarter, Crusader’s reserves for each accident year (i.e., for all claims occurring within each year) are re-evaluated independently by the Company’s president, the Company’s chief financial officer, and an independent consulting actuary. Generally accepted actuarial methods, including the widely used Bornhuetter-Ferguson and loss development methods, are employed to estimate ultimate claims costs. An actuarial central estimate of the ultimate claims’ costs and IBNR reserves is ultimately determined by management and tested for reasonableness by the independent consulting actuary. The Company determines the number of reported claims based on the number of loss events. A claim is considered a single loss event, per policy, and it may include multiple claimants and multiple coverages on a single policy. The cumulative number of reported claims is a sum of open claims, closed claims, and claims closed without payment.

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs	12 Months Ended
	Dec. 31, 2021
Deferred Policy Acquisition Costs
Deferred Policy Acquisition Costs	NOTE 9 – DEFERRED POLICY ACQUISITION COSTS The following table provides an analysis of the roll forward of the Company’s deferred policy acquisition costs: Year ended December 31 2021 2020 Deferred policy acquisition costs at beginning of year $ 3,503,248 $ 3,619,594 Policy acquisition costs deferred during year 2,926,203 4,782,461 Policy acquisition costs amortized during year (5,442,645 ) (4,898,807 ) Deferred policy acquisition costs at end of year $ 986,806 $ 3,503,248 Deferred policy acquisition costs consist of commissions (net of ceding commission), premium taxes, inspection fees, and certain other underwriting costs, which are related to and vary with the production of Crusader policies. Policy acquisition costs are deferred and amortized as the related premium is earned. Deferred acquisition costs are reviewed to determine if they are recoverable from future income on insurance policies generated from these costs, including investment income. The Company recognized an allowance against its deferred acquisition costs of $1,409,654 and $0 for the years ended December 31, 2021 and 2020, respectively.

Acccrued Expenses and Other Lia

Acccrued Expenses and Other Liabilities	12 Months Ended
	Dec. 31, 2021
Acccrued Expenses and Other Liabilities
Acccrued Expenses And Other Liabilities	NOTE 1 0 – ACCRUED EXPENSES AND OTHER LIABILITIES Accrued expenses and other liabilities consist of the following: Year ended December 31 2021 2020 Premium payable $ 508,147 $ 393,466 Unearned policy fee income 224,536 454,883 Retirement plans 12,413 145,473 Accrued salaries and employee benefits 53,449 973,504 Commission payable (251 ) 869 Security deposit for Calabasas Building sale - 380,850 Other 1,467,943 1,228,405 Total accrued expenses and other liabilities $ 2,266,237 $ 3,577,450

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies
Commitments And Contingencies	NOTE 11 – COMMITMENTS AND CONTINGENCIES The Company, by virtue of the nature of the business conducted by it, becomes involved in numerous legal proceedings as either plaintiff or defendant. From time to time, the Company is required to resort to legal proceedings against vendors providing services to the Company or against customers or their agents to enforce collection of premiums, commissions, or fees. These routine items of litigation do not materially affect the Company and are handled on a routine basis by the Company through its counsel. Crusader is also subject to regulatory and governmental examinations, requests for information, inquiries, investigations, and threatened legal actions and proceedings by state regulators and others. Crusader receives numerous requests, orders for documents, and information in connection with various aspects of its regulated activities. Regulatory and governmental requests for information, inquires, certain examinations and investigations are routinely handled by Crusader. Crusader may involve outside counsel in regulatory matters depending on the nature of the matter. The Company establishes reserves for lawsuits, regulatory actions, and other contingencies for which the Company is able to estimate its potential exposure and believes a loss is probable. For loss contingencies believed to be reasonably possible, the Company discloses the nature of the loss contingency, an estimate of the possible loss, a range of loss, or a statement that such an estimate cannot be made. Likewise, the Company is sometimes named as a cross‑defendant in litigation, which is principally directed against an insured who was issued a policy of insurance directly or indirectly through Crusader. Incidental actions related to disputes concerning the issuance or non‑issuance of individual policies are sometimes brought by customers or others. These items are also handled on a routine basis by counsel, and they do not generally affect the operations of the Company. Management is confident that the ultimate outcome of pending litigation should not have an adverse effect on the Company’s consolidated results of operations or financial position. The Company vigorously defends itself unless a reasonable settlement appears appropriate. Crusader has received a number of coronavirus-related business interruption claims. With the exception of one claim for which the investigation is still ongoing, all such claims were denied after the individual circumstances of each claim were reviewed to determine whether insurance coverage applied. Like many companies in the property casualty insurance industry, Crusader was named as defendant in lawsuits seeking insurance coverage under the policies issued by Crusader for alleged economic losses resulting from the shutdown or suspension of their businesses due to COVID-19. Although the allegations vary, the plaintiffs generally seek a declaration of insurance coverage, damages for breach of contract in unspecified amounts for claim denials, interest, and attorney fees. Some of the lawsuits also allege that the insurance claims were denied in bad faith or otherwise in violation of state laws and seek extra-contractual or punitive damages. Crusader denies the allegations in these lawsuits and intends to continue to vigorously defend them. Although the policy terms vary in general, the claims at issue in these lawsuits were denied because the policyholder identified had no direct physical loss, such as fire or water damage, to property at the insured premises, and the governmental orders that led to the complete or partial shutdown of the business were not due to the existence of any direct physical loss or damage to property in the immediate vicinity of the insured premises and did not prohibit access to the insured premises, as required by the terms of the insurance policies. Depending on the individual policy, additional policy terms and conditions may also prohibit coverage, such as exclusions for pollutants, ordinance or law, loss of use, and acts or decisions. Most of Crusader’s policies also contain an exclusion for losses caused directly or indirectly by “virus or bacteria.” In addition to the inherent difficulty in predicting litigation outcomes, COVID-19 business income coverage lawsuits present a number of uncertainties and contingencies that are not yet known, including how many policyholders will ultimately file claims, the number of lawsuits that will be filed, the extent to which any class may be certified, and the size and scope of any such classes. The legal theories advanced by plaintiffs vary by case. These lawsuits are in the early stages of litigation; many complaints continue to be amended; several have been dismissed voluntarily and may be refiled; and others have been dismissed by trial courts. Some early decisions on motion filings have been appealed. On March 23, 2021, ten policyholders sued Crusader in a putative class action entitled Anchors & Whales LLC et al. v. Crusader Insurance Company Crusader has received seven claims related to civil unrest through July 11, On May 9, 2022, Donald Esparza filed an action in the Superior Court of California, County of Los Angeles, against the Company, Michael Budnitsky and Steven L. Shea (22VECV00627) relating to the termination of the employment of Mr. Esparza by the Company. The action is entitled Donald Esparza v. Unico American Corporation, Michael Budnitsky and Steven Shea ( The action alleges that the Company (i) failed to timely pay wages upon termination of employment in violation of the California Labor Code (ii) failure to provide accurate itemized wage statements in violation of the California Labor Code (iii) violated the California unfair competition law by the forgoing alleged violations of the California Labor Code; and (iv) failure to provide the personnel file of Mr. Esparza after written demand in violation of the California Labor Code. The action seeks general and statutory damages, including without limitation lost wages, back pay, front pay, and lost earning capacity; special damages, statutory penalties and other relief, including reasonable attorneys’ fees. The employment of Mr. Esparza, a former officer, director and employee of Crusader, was terminated in connection with a reduction in force of employees in connection with the runoff of Crusader. Defendant Budnitsky is a former officer of the Company and Crusader. Defendant Shea is the current Chairman of the Board, President and Chief Executive Officer of the Company and Crusader. The Company cannot predict the eventual outcome of the Esparza litigation, whether there will be an ultimate resolution, or any eventual loss, fines or penalties related to the action. It is the intent of the Company to vigorously defend the action brought against it by Mr. Esparza.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2021
Reinsurance
NOTE 12 - REINSURANCE	NOTE 12 – REINSURANCE A reinsurance transaction occurs when an insurance company transfers (cedes) a portion of its exposure on policies written to a reinsurer that assumes that risk for a premium (ceded premium). Reinsurance does not legally discharge Crusader from primary liability under its policies. If the reinsurer fails to meet its obligations, Crusader must nonetheless pay its policy obligations. Crusader’s primary excess of loss reinsurance agreements, or treaties, during the years ended December 31, 2021 and 2020, with Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE which are both A+ rated. Crusader’s retention on losses is $500,0000 under these contracts. Reinsurance treaties are generally structured in layers, with different negotiated economic terms and retention of participation, or liability, in each layer. The effect of reinsurance on written premium, earned premium, and incurred losses and loss adjustment expenses is as follows: Year ended December 31 2021 2020 Written premium: Direct $ 32,871,625 $ 36,338,800 Assumed 3,395,010 304,030 Ceded (11,551,580 ) (8,078,748 ) Net written premium $ 24,715,055 $ 28,564,082 Earned premium: Direct $ 38,278,730 $ 36,108,230 Assumed 1,844,931 156,639 Ceded (11,693,756 ) (8,096,701 ) Net earned premium $ 28,429,905 $ 28,168,168 Year ended December 31 2021 2020 Incurred losses and loss adjustment expenses: Direct $ 35,218,127 $ 48,971,172 Assumed 836,622 89,204 Ceded (10,081,909 ) (14,417,456 ) Net incurred losses and loss adjustment expenses $ 25,972,840 $ 34,642,920 Ceded earned premium as a percentage of gross earned premium (direct and assumed earned premium) was 29% in 2021 and 22% in 2020. Crusader’s primary excess of loss reinsurance agreements during the years ended December 31, 2021 and 2020 are as follows: Loss Year Reinsurers A.M. Best Rating Retention 2021 Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE A+ A+ $ 500,000 2020 Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE A+ A+ $ 500,000 Crusader’s primary excess of loss reinsurance agreements, or treaties, during the years ended December 31, 2021 and 2020, are with Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE, both A+ rated. In calendar years 2021 and 2020, Crusader retained a participation in its excess of loss reinsurance treaties of 0% in its 1 st nd Crusader also has catastrophe (“CAT”) reinsurance treaties from various highly rated California authorized and California unauthorized reinsurance companies. These reinsurance treaties help protect Crusader against losses in excess of certain retentions from catastrophic events that may occur on property risks which Crusader insures. In calendar years 2021 and 2020, Crusader retained a participation in its catastrophe excess of loss reinsurance treaties of 5% in its 1 st nd Crusader also has facultative reinsurance treaties from a highly rated California authorized reinsurance company. Unlike the excess of loss treaties which cover all risks underwritten by Crusader, the facultative reinsurance treaties cover specific risks for properties with total insured values in excess of $4,000,000, (the property coverage limit of the excess of loss treaties). In calendar year 2020 and during the first five months of 2021, the facultative reinsurance treaties provided coverage for reinsured losses between $4,000,000 and $8,000,000. From June 2021, the facultative reinsurance treaties had two sections which provide coverage for reinsured losses between $4,000,000 and $9,000,000 (Section A) and $4,000,000 and $15,000,000 (Section B) depending on location of the insured risk On April 1, 2020, Crusader and Unifax entered into a reinsurance arrangement with USIC), pursuant to which USIC would underwrite property and casualty insurance policies by and through Unifax and such policies would be reinsured by Crusader. On September 2, 2020, the Company placed a moratorium on placing any new risks with USIC by Unifax pending negotiations among Crusader, Unifax, and USIC pursuant to the issues raised by the DOI regarding the structure of the reinsurance arrangement and its compliance with the California Insurance Holding Company System Act (the “Insurance Act”). On November 24, 2020, as a result of such negotiations with the DOI, Crusader, Unifax and USIC agreed to rescind certain agreements by and among USIC, Crusader and Unifax. The effect of such rescissions was that the rescinded agreements were deemed never to have existed and no insurance policies were deemed issued, and no premium deemed written, collected or reported with respect to those agreements. Further, on November 24, 2020, the parties entered into various restructured arrangements in order to address the issues raised by the DOI with respect to California insurance laws. In particular, the parties eliminated all intercompany duties so that the arrangement would not require prior approval by the DOI under the Insurance Act. Details of the restructured arrangements with USIC include the following: · On November 24, 2020, USIC and Crusader entered into a new Quota Share Reinsurance Agreement, effective April 1, 2020, (the “New Reinsurance Agreement”), pursuant to which Crusader will reinsure all of USIC’s liability for policies issued by USIC and produced by Unifax for property, general liability, CMP property, CMP liability and other miscellaneous coverages, subject to certain maximum policy limits. Policies placed with USIC by Unifax and reinsured with Crusader prior to November 24, 2020 remain in place without interruption or change and are subject to the New Reinsurance Agreement. · On November 24, 2020, USIC and Unifax entered into a Surplus Line Broker Agreement, effective April 1, 2020 (the “Broker Agreement”), pursuant to which, and subject to the terms, conditions and limitations set forth therein, USIC authorized Unifax to act as its broker and agent for the purpose of producing and administering certain specified classes of insurance policies, which are the subject of the New Reinsurance Agreement. Under the Broker Agreement, Unifax is entitled to retain a commission for policies produced based on a percentage of the premiums on business placed with USIC. Unifax has agreed to indemnify and hold USIC harmless from any losses relating to the Broker Agreement. The Broker Agreement may be terminated in specified events, including by any party upon 90 days written notice to the other parties and automatically upon cancellation or termination of the New Reinsurance Agreement. · On November 24, 2020, USIC and U.S. Risk Managers, Inc. (“U.S. Risk”), a subsidiary of the Company, entered into a Claims Administration Agreement, effective as of April 1, 2020 (the “Claims Administration Agreement”). Pursuant to the Claims Administration Agreement, USIC appointed U.S. Risk, which is a licensed claims adjuster in the state of California, to adjust and settle claims on its behalf in connection with the surplus lines policies issued by USIC in connection with the New Reinsurance Agreement. U.S. Risk will be paid a fee by Unifax on behalf of USIC based on a percentage of earned premium. U.S. Risk will establish an account for payment of claims by U.S. Risk (the “Loss Fund Account”) pursuant to the Claims Administration Agreement. Pursuant to the terms of the New Reinsurance Agreement, Crusader will fund the Loss Fund Account provided for in the Claims Administration Agreement on behalf of USIC.U.S. Risk has agreed to indemnify and hold USIC harmless from any losses relating to the Claims Administration Agreement. The Claims Administration Agreement may be terminated in specified events, including by any party upon 90 days written notice to the other parties and automatically upon cancellation or termination of the Broker Agreement. Termination of Reinsurance Arrangement On August 31, 2021, Crusader and United Insurance Company ("USIC"), terminated the Quota Share Reinsurance Agreement ( the "Reinsurance Agreement") effective April 1, 2020, by and between Crusader and USIC. Pursuant to the Reinsurance Agreement, Crusader agreed to reinsure all of USIC's liability for policies issued by USIC and produced by Unifax, for property, general liability, commercial multiple peril ("CMP"), liability and other miscellaneous coverages, subject to certain maximum policy limits. Crusader's obligations under the Reinsurance Agreement continue after termination but issued after termination for business in force at the time of termination, for policies with effective dates prior to the termination but issued after the termination date, and for policies that must be issued or renewed as a matter of law until the expiration of the policies. On August 31, 2021, as result of the termination of the Reinsurance Agreement, the Surplus Line Broker Agreement (the "broker Agreement") effective April 1, 2020, by and between Unifax and USIC, automatically terminated. pursuant to the Broker agreement, USIC authorized Unifax to act as its broker for the purpose of producing and administering certain specified classes of insurance policies, which are the subject of the Reinsurance Agreement. Unifax's obligations under the Broker Agreement continue after termination for insurance business reinsured under the Broker Agreement. Unifax's obligations including handling and servicing of all policies until their expiration. On August 31, 2021, as a result of the termination of the Broker Agreement, the Claims Administration Agreement (the " Claims Administration Agreement"), effective April 1, 2020, by and between U.S. Risk and USIC, automatically terminated. pursuant to the Claims Administration Agreement, USIC appointed U.S. risk to adjust and settle claims on its behalf in connection with the surplus lines policies issued by USIC in connection with the Reinsurance Agreement. Upon termination of the Claims Administration Agreement, U.S. Risk is obligated (unless revoked by USIC) to continue to manage claims during the runoff of the business reinsured. The Reinsurance Agreement was mutually terminated by Crusader and USIC. There were no early termination penalties incurred as a result of the termination. The Reinsurance Agreement provides for a minimum ceding fee, and, upon termination of the Reinsurance Agreement, the minimum ceding fee was pro-rated to the date of termination unless there were policies issued after the termination of the Reinsurance Agreement. In such case, the minimum ceding fee will continue past the termination of the Reinsurance Agreement until such time as no further policies are issued. USIC waived any additional ceding fees payable under the Reinsurance Agreement under the agreement to terminate that agreement. Under the Reinsurance Agreement, Crusader was required to secure its obligations to USIC for unearned premium reserves, if any, and loss reserves (losses incurred and not reported and loss reported but unpaid) in a security fund, trust agreement or letter of credit to permit USIC to receive credit for the reinsurance ceded to Crusader by USIC. Such security was required because crusader is not authorized to transact insurance in Delaware the domiciliary state of USIC. Initially, the security required to be provided by Crusader was 150% of the unearned premium and loss reserves. USIC was permitted to request additional security for the unearned premium and loss reserves in the event (i) the A.M. Best rating Crusader is at any time reduced; or (ii) the A.M. Best rating of Crusader is at any time removed or withdrawn; or (iii) there is a reduction the capital and policyholder surplus of Crusader by 10% or more in any rolling 12-month period or (iv) Crusader fails to maintain its Cat excess of loss reinsurance coverage at certain levels. As of December 31, 2021, six securities were held as collateral with Comerica, pursuant to the reinsurance trust agreement among crusader, USIC and Comerica to secure payment of Crusader's liabilities and performance of its obligation under the reinsurance with USIC. The estimated fair value and amortized cost of those securities was $8,243,758 and $8,162,053 on December 31, 2021, respectively. The estimated aggregate fair value and amortized cost of these securities was $7,944,916 and $7,836,756, on March 31, 2022, respectively. As of April 30, 2022, the estimated market value decreased to $7,663,701. Such market values are used in the trust fund calculation by USIC . The increase in the security request is a result of a decline in the market value of the securities and an increase in the collateral from 150% to 325% because of Crusade's loss of the AM best rating and the decline in policyholder surplus. If Crusader fails to provide the additional security requested by USIC, USIC may draw down the full amount of the funds in the reinsurance trust agreement. Crusader is reviewing the request of USIC and believes that the asserted loss reserves used in their calculation may be incorrect. Any increase to the reinsurance trust agreement by Crusader will require the consent of the Special examiner. Any drawdown of the reinsurance of the reinsurance trust agreement by USIC may have a materially adverse effect on the financial condition of Unico. As of December 31, 2020, one corporate security, included in available-for-sale fixed maturities, was held as collateral with Comerica, pursuant to the reinsurance trust agreement among Crusader, USIC and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC. The estimated fair value and amortized cost of that security was $824,500 and $787,653 on December 31, 2020, respectively. Crusader has no reinsurance recoverable balances in dispute.

Profit Sharing Plan

Profit Sharing Plan	12 Months Ended
	Dec. 31, 2021
Profit Sharing Plan
Profit Sharing Plan	NOTE 13 – PROFIT SHARING PLAN The Unico American Corporation Profit Sharing Plan (“ Plan Contributions to the Plan are as follows: Year ended December 31, 2021 $ 171,205 Year ended December 31, 2020 $ 154,331

Statutory Capital and Surplus

Statutory Capital and Surplus	12 Months Ended
	Dec. 31, 2021
Statutory Capital and Surplus
Statutory Capital And Surplus	NOTE 14 – STATUTORY CAPITAL AND SURPLUS Crusader is required to file statutory financial statements with insurance regulatory authorities prepared on an accounting basis prescribed or permitted by such authorities. Statutory accounting practices differ in certain respects from GAAP. The more significant of the differences for statutory accounting practices are (a) policy acquisition and commission costs are expensed when incurred rather than over the periods covered by the policies; (b) fixed maturity securities are reported at amortized cost, or the lower of amortized cost or fair value, depending on the quality of the security as specified by the National Association of Insurance Commissioners (“NAIC”); (c) non-admitted assets are charged directly against surplus; (d) loss and loss adjustment expense reserves and unearned premium reserves are stated net of reinsurance; (e) federal income taxes are recorded when payable and deferred taxes, subject to limitations, are recognized but only to the extent that they do not exceed a specified percentage of statutory surplus; and (f) changes in deferred taxes are recorded directly to surplus as regards policyholders. Additionally, the cash flow presentation is not consistent with GAAP and reconciliation from net income to cash provided by operations is not presented. Comprehensive income is not presented under statutory accounting practices. Crusader’s statutory capital and surplus are as follows: As of December 31, 2021 $ 22,494,454 As of December 31, 2020 $ 26,893,515 Crusader’s statutory net loss is as follows: Year ended December 31, 2021 $ (1,774,020 ) Year ended December 31, 2020 $ (12,862,588 ) The (“CA DOI”) conducts periodic financial examinations of Crusader. The last exam was performed in 2017. The Company has complied with all comments and recommendations identified in the report of examination, and none of the issues in that report of examination had any material effect on Crusader. Crusader is restricted in the amount of dividends it may pay to its parent in any 12-month period without prior approval of the CA DOI. Generally, without prior regulatory approval, insurance companies may pay a dividend in any 12-month period up to the greater of (a) 10% of its statutory surplus or (b) its statutory net income for the preceding calendar year. Reference is made to Note 1 regarding the Supervision Agreement with CA DOI that requires CA DOI approval of all dividends effective September 7, 2021. The CA DOI advised in April 2021, the Crusader was prohibited from paying dividends during the 2021 and for the years 2022 through 2025. During the years ended December 31, 2021 and 2020, Crusader issued cash dividends of $0 and $4,000,000 to Unico, respectively. On December 31, 2021 and December 31, 2020, Crusader's RBC Level was less than 300% of its Authorized Control Level RBC, and its statutory accounting basis combined ratio was in excess of 120% for the year then ended. The RBC Level when coupled with statutory accounting basis combined ratio triggered Company Action Events under the RBC for the years then ended. On March 24, 2021 Crusader submitted to the CA DOI a comprehensive Risk Based Capital Plan (the " RBC Plan 2022 RBC Plan

Stock Plans

Stock Plans	12 Months Ended
	Dec. 31, 2021
Stock Plans
Stock Plans	NOTE 1 5 – STOCK PLANS The Company’s 2021 Equity Incentive Plan (the "Equity Incentive Plan") covers 500,000 shares of Unico's common stock (subject to adjustment in the case of merger, consolidation, reorganization, recapitalization, stock split, reverse stock split, split up, spin-off, combination of shares, exchange of shares, stock dividend, dividend in kind, etc.) and was approved by Unico’s stockholders on May 27, 2021. The Equity Incentive Plan provides for the grant of the following equity-based incentive awards to participants: (i) non-qualified stock options, (ii) stock appreciation rights, (iii) restricted stock, (iv) restricted stock units and (v) other stock-based awards. Through the date of this filing, there have been 44,250 non-qualified stock options granted, 30,000 were forfeited and 14,250 outstanding. and 48,000 restricted stock grants, 31,000 forfeited with 17,000 outstanding under the Equity Incentive Plan, of which none were vested and exercisable. The exercise price, term, and other conditions applicable to each non-qualified stock option and restricted stock granted under the Equity Incentive Plan are determined by the Company’s Compensation Committee of the Board of Directors. The exercise price of the stock options is set on the grant date and may not be less than the fair market value per share of the Company’s stock on that date (at market close). The non-qualified stock options granted under the Plan in 2021 vest 25% on the first anniversary of the grant date and 25% annually thereafter on the anniversary date and expire four years after the date of the grant. The restricted stock grants granted under the Plan in 2021 vest 100% on the fourth anniversary of the grant date. The Company recognized stock-based compensation expense in the amount of $11,589 for all awards issued under the Equity Incentive Plan in the “Salaries and employee benefits” line item in the Consolidated Statements of Operations for the year ended December 31, 2021. The fair value of each option award is estimated on the date of the grant using the Black-Scholes Option-Pricing Model using a number of complex and subjective variables. These variables include expected stock price volatility over the term of the awards, a risk-free interest rate and expected dividends. Expected dividend yield is based on the historical dividend behavior as well as the expected dividend behavior of the Company. Expected volatility is based on the historical volatility of the Company’s stock. The risk-free rate for periods within the contractual life of the option is based on the U.S. treasury yield curve for a 30-day treasury in effect at the time of grant. The expected term represents an estimate of time the options are expected to remain outstanding. In accordance with ASC Topic 718, “Compensation – Stock Compensation,” the Company estimates forfeitures at the time of the grant and revises those estimates in subsequent periods if the actual forfeitures differ from those estimates. The assumptions used to value each option award granted during the year ended December 31, 2021, are as follows: Weighted-average grant date fair value $ 4.52 Expected dividend yield 0.00 % Expected volatility 96.35 % Risk-free interest rate 0.09 % Expected term (years) 4.00 Expected forfeiture 50.00 % The following table summarizes non-qualified stock option and restricted stock grants activity for the year ended December 31, 2021: Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Terms Aggregate Intrinsic Value Outstanding at December 31, 2020 - - - - Non-qualified stock option granted 14,250 $ 4.52 4.00 - Restricted stock granted 17,000 4.52 4.00 - Forfeited or expired (61,000 ) 4.52 - - Exercised - - - - Outstanding at December 31, 2021 31,250 $ 4.52 3.79 - Exercisable at December 31, 2021 - - - - The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the Company’s closing stock price and the exercise price, multiplied by the number of in the money options) that would have been received by the option holders had all options been exercised on December 31, 2021. Options were granted to employees during 2021. Unrecognized compensation cost was $152,003 as of December 31, 2021 and is expected to be recognized over a weighted-average exercise period of 3.74 years. As of December 31, 2021, 500,000 shares of the Company’s common stock were available under the Equity Incentive Plan.

Taxes on Income

Taxes on Income	12 Months Ended
	Dec. 31, 2021
Taxes on Income
Taxes On Income	NOTE 1 6 – TAXES ON INCOME The provision for taxes on income consists of the following: Year ended December 31 2021 2020 Federal expense Deferred 450,117 3,566,840 Total tax expense $ 450,117 $ 3,566,840 State expense Current $ 8,800 $ 8,800 Deferred - (28,042 ) Total tax expense (benefit) $ 8,800 $ (19,242 ) Total expense Current $ 8,800 $ 8,800 Deferred 450,117 3,538,798 Total tax expense $ 458,917 $ 3,547,598 The income tax provision reflected in the Consolidated Statements of Operations is different than the expected federal income tax rate of 21% on income as shown in the following table: Year ended December 31 2021 2020 Computed income tax benefit at 21% $ (1,095,010 ) $ (3,768,138 ) Tax effect of: State tax expense (benefit), net of federal tax benefit 137,312 (572,511 ) Change in valuation allowance – state net operating losses (130,360 ) 557,310 Change in valuation allowance – federal 1,547,392 7,319,959 Other, including nondeductible expenses 3,620 10,920 Other – prior year true up (4,037 ) 58 Income tax expense $ 458,917 $ 3,547,598 Significant components of the Company’s net deferred tax assets and liabilities are as follows: Year ended December 31 2021 2020 Deferred tax assets: Discount on loss reserves $ 605,164 $ 531,845 Unearned premium 599,571 759,659 Unearned commission income - 438,574 Unearned policy fee income 62,834 127,293 Net operating loss carryforwards 8,584,487 7,769,603 State net operating loss carryforwards 2,509,115 2,402,438 Unrealized losses on investments - - Bad debt reserve 62,673 333,649 Other 474,854 237,803 Total gross deferred tax assets 12,898,698 12,600,864 Less valuation allowance 11,939,459 10,557,080 Total deferred tax assets $ 959,239 $ 2,043,784 Deferred tax liabilities: Policy acquisition costs $ 191,586 $ 858,705 State tax on undistributed insurance company earnings 25,357 84,219 Federal tax liability on state deferred tax assets 63,456 91,277 Depreciation and amortization 302,073 266,880 Unrealized gains on investments 376,767 742,703 Total deferred tax liabilities $ 959,239 $ 2,043,784 Net deferred tax assets $ - $ - The Company recognizes deferred tax assets and liabilities for the future tax consequences related to differences between the financial statement carrying amounts of existing assets and liabilities and the respective tax bases, and for tax credits. The Company evaluates its deferred tax assets for recoverability based on available evidence, including assumptions about future profitability, reversal patterns of recorded deferred tax assets and deferred tax liabilities, and capital gain generation. Some or all of the Company’s deferred tax assets could expire unused if the Company is unable to generate taxable income of a sufficient nature in the future to utilize them. If the Company determines it is more-likely-than-not that it would not be able to realize all or a portion of its deferred tax assets in the future, the Company will reduce the deferred tax asset through a charge to earnings in the period in which the determination is made. This charge could have a materially adverse effect on the Company’s results of operations and financial condition. In addition, the assumptions used to make this determination are subject to change from period to period based on changes in tax laws or variances between the Company’s projected operating performance and actual results. As a result, management’s judgment is required in assessing the possible need for a deferred tax asset valuation allowance. As of December 31, 2021, the Company had deferred tax assets of 8,584,487 generated from 40,878,510 of federal net operating loss carryforwards that will begin to expire in 2035 and deferred tax assets of $2,509,115 generated from state net operating loss carryforwards which begin to expire in 2028. In connection with preparation of its consolidated financial statements, the Company periodically performs an analysis of future income projections to determine the adequacy of the valuation allowance. In light of the net losses that were generated in recent years, for the years ended December 31, 2021 and December 31, 2020, the Company has established a full valuation allowance against all deferred tax assets in the amount of $11,939,459 and $10,557,080, respectively. The current federal effected state tax rate is 6.98%. The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and AAC are allocated taxes, or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2018 and California state income tax authorities for tax returns filed starting at taxable year 2017. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states where Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. As of December 31, 2021, the Company had no unrecognized tax benefits, no unrecognized additional liabilities or reduction in deferred tax asset, and no uncertain tax positions. In addition, the Company had not accrued interest and penalties related to unrecognized tax benefits. However, if interest and penalties would need to be accrued related to unrecognized tax benefits, such amounts would be recognized as a component of federal income tax expense.

Repurchase of Common Stock-Effe

Repurchase of Common Stock-Effect on Stockholders' Equity	12 Months Ended
	Dec. 31, 2021
Repurchase of Common Stock-Effect on Stockholders' Equity
Repurchase Of Common Stock	NOTE 1 7 – REPURCHASE OF COMMON STOCK – EFFECT ON STOCKHOLDERS’ EQUITY On August 10, 2020, the Board authorized a share repurchase program (the “ 2020 Program December 31 December 31 2021 2020 2020 Program Number of shares repurchased 22 857 Cost of shares repurchased Allocated to retained earnings $ 91 $ 4,071 Allocated to capital 10 422 Total cost of shares repurchased $ 101 $ 4,493 2008 Program Number of shares repurchased - 978 Cost of shares repurchased Allocated to retained earnings - $ 5,760 Allocated to capital - 480 Total cost of shares repurchased $ - $ 6,240 The Company has remaining authority under the 2020 Program to repurchase up to $4,995,406 of the currently outstanding shares of the Company’s common stock as of December 31, 2020. The Company has retired or will retire all stock repurchased under the 2020 Program and 2008 Program. Effective January 2022, the Company suspended the 2020 Program and ceased any further repurchases of its shares from stockholders from the Company.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2021
Related Party Transactions
Related Party Transactions	NOTE 1 8 – RELATED PARTY TRANSACTIONS Altonji Consulting, LLC, owned by Gerard Altonji, a member of the Company’s Board of Directors, was engaged to provide consulting services for a $20,000 fee of which $15,000 was paid during the year ended December 31, 2020.

Loss Per Share

Loss Per Share	12 Months Ended
	Dec. 31, 2021
Loss Per Share
Loss Per Share	NOTE 1 9 – LOSS PER SHARE A reconciliation of the numerator and denominator used in the basic and diluted loss per share calculation is presented as follows: Year ended December 31 2021 2020 Basic Loss Per Share Net loss numerator $ (5,673,251 ) $ (21,491,113 ) Weighted average shares outstanding denominator 5,304,872 5,305,829 Per share amount $ (1.07 ) $ (4.05 ) Diluted Loss Per Share Net loss numerator $ (5,673,251 ) $ (21,491,113 ) Weighted average shares outstanding 5,304,872 5,305,829 Effect of diluted securities - - Diluted shares outstanding denominator 5,304,872 5,305,829 Per share amount $ (1.07 ) $ (4.05 ) As of December 31, 2021, and 2020, the Company had no common share equivalents that were excluded in the diluted loss per share calculation for years ended December 31, 2021 and 2020.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income	NOTE 20 – ACCUMULATED OTHER COMPREHENSIVE INCOME The table below details the components of accumulated other comprehensive income at year end Pre-Tax Amount Tax (Expense) Benefit Net-of-Tax Amount December 31, 2020 $ 3,338,414 $ (701,067 ) $ 2,637,347 Changes in unrealized loss on available-for-sale securities (2,025,511 ) 425,357 $ (1,600,154 ) Reclassification adjustment for gains included in net loss (117,903 ) 24,760 $ (93,143 ) December 31, 2021 $ 1,195,000 $ (250,950 ) $ 944,050 December 31, 2019 $ 1,497,299 $ (314,433 ) $ 1,182,866 Changes in net unrealized gain on investments 1,905,367 (400,127 ) $ 1,505,240 Reclassification adjustment for net realized gains included in net loss (642,524 ) 13,493 $ (50,760 ) December 31, 2020 $ 3,338,413 $ (701,067 ) $ 2,637,347

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2021
Subsequent Events
Subsequent Events	NOTE 21 – SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions for potential recognition or disclosure through the date the consolidated financial statements were issued. Except as disclosed below and elsewhere, no events have occurred subsequent to December 31, 2021 requiring disclosure or recording in the consolidated financial statements. New Lease On January 11, 2022, Crusader entered into a sublease agreement (the “ New Lease Western General Premises The term of the New Lease commenced on February 1, 2022 (the “ Commencement Date Beginning on the Commencement Date, Crusader is obligated to make monthly rent payments in an amount of $10,539. In addition, Crusader is obligated to pay Western General its proportionate share, 5.45%, of operating expenses. Crusader was also required to deliver to Western General an initial payment of $20,539, $10,000 of which is held by Western General as a refundable security deposit. Further outsourcing of Claims Processing In January 2022 Crusader engaged a third-party administrator (“ TPA Further Significant Reduction in Premium Trust Account Deficiency with Unifax In January 2022 Unico, Crusader, and Unifax agreed, with the pre-approval of the Special Examiner, to transfer a computer system, owned by Unico, to Crusader. Unico contributed the computer system at its book value of $1,991,956 to Unifax, and Unifax in turn contributed the computer system to Crusader at its book value of $1,991,956 as a direct reduction in the amount due to Crusader which resulted in a dollar-for-dollar reduction in the premium deficiency. The amount of such deficiency was $275,901 as of March 31, 2022, and $432,900 as of May 31, 2022.

Selected Quarterly Financial Da

Selected Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2021
Selected Quarterly Financial Data (Unaudited)
Selected Quarterly Financial Data (unaudited)	NOTE 22 – SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED) Summarized unaudited quarterly financial data for each of the calendar years 2021 and 2020 is as follows: Comparable Period by Quarter Ended March 31 June 30 September 30 December 31 Calendar Year 2021 Total revenues $ 11,471,654 $ 8,132,605 $ 8,595,648 $ 8,188,477 Income (loss) before taxes $ 2,542,339 $ (1,430,835 ) $ (2,450,619 ) $ (3,875,219 ) Net income (loss) $ 2,267,703 $ (1,406,811 ) $ (2,510,198 ) $ (4,023,945 ) Income (loss) per share: Basic and Diluted $ 0.43 $ (0.27 ) $ (0.47 ) $ (0.76 ) Calendar Year 2020 Total revenues $ 8,005,181 $ 7,976,227 $ 8,259,686 $ 8,319,017 Loss before taxes $ (1,145,498 ) $ (384,562 ) $ (14,345,916 ) $ (2,067,539 ) Net loss $ (1,043,826 ) $ (434,814 ) $ (17,940,488 ) $ (2,071,985 ) Loss per share: Basic and Diluted $ (0.20 ) $ (0.08 ) $ (3.38 ) $ (0.39 )

Supplementary Information on Lo

Supplementary Information on Loss and ALAE Development (Unaudited)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Supplementary Information On Loss And Alae Development (unaudited)	NOTE 22 – SUPPLEMENTARY INFORMATION ON LOSS AND ALAE DEVELOPMENT (UNAUDITED) The following table presents cumulative incurred losses and ALAE, net of reinsurance, for years ended December 31: Accident Year 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 2012 $ 18,511,598 19,532,022 18,895,666 18,344,175 18,050,131 17,914,837 18,235,335 18,355,031 18,327,346 18,353,966 2013 $ 19,570,946 20,118,343 20,323,841 21,742,580 22,798,398 22,397,394 22,859,132 22,802,931 22,852,457 2014 $ 16,884,731 15,394,995 14,930,960 17,640,211 18,034,749 17,898,306 18,048,285 17,965,556 2015 $ 20,452,199 20,840,034 22,471,512 21,707,615 23,006,844 24,495,614 25,332,806 2016 $ 21,646,663 22,908,016 24,126,775 25,677,378 26,337,621 27,006,706 2017 $ 21,914,736 23,453,130 23,876,588 25,091,934 26,103,135 2018 $ 19,048,233 18,099,500 20,670,880 19,179,716 2019 $ 17,349,941 19,182,851 18,723,515 2020 $ 24,302,958 22,611,110 2021 $ 23,198,334 (1) The information for the years 2012 through 2020 is presented as unaudited required supplementary information. The following table presents cumulative paid losses and ALAE, net of reinsurance, for years ended December 31: Year 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021(1) 2012 $ 6,719,982 $ 11,673,621 13,411,125 15,369,629 16,734,967 17,265,513 17,638,646 18,001,581 18,020,565 18,355,881 2013 $ 7,594,731 10,656,777 14,319,057 19,067,334 21,415,490 21,875,978 22,364,215 22,802,275 22,849,314 2014 $ 3,826,263 6,082,893 9,173,947 14,556,687 16,843,128 17,487,722 17,806,537 17,817,189 2015 $ 6,263,796 11,151,955 14,978,639 17,700,688 20,148,880 21,502,400 23,197,570 2016 $ 7,435,120 12,009,273 15,916,432 21,438,785 23,326,143 24,528,218 2017 $ 6,405,641 11,503,228 15,289,400 18,869,369 21,188,239 2018 $ 4,959,689 9,254,754 12,129,118 13,750,695 2019 $ 4,292,275 7,603,418 10,898,586 2020 $ 6,004,292 9,769,654 2021 $ 5,027,785 (1) The information for the years 2012 through 2020 is presented as unaudited required supplementary information. The following table presents average annual percentage payout of incurred claims by age, net of reinsurance as of December 31, 2021: Years 1 2 3 4 5 6 7 8 9 10 27.5 % 17.8 % 16.1 % 16.2 % 9.0 % 4.1 % 2.1 % 0.8 % 0.3 % 0.3 % The percentages in the above table do not add up to 100% because the percentages represent averages across all accident years at each development stage.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Nature Of Business	Unico American Corporation (the “ Company Unico During the quarter ended September 30, 2021, Unico took actions to cause its subsidiary, Crusader Insurance Company (“Crusader”), to enter into runoff. In connection with its runoff, Crusader began to cease writing new and renewal business and to wind down operations that support the writing of insurance policies. Effective September 30, 2021, Crusader ceased writing any new insurance policies and no longer renews policies after December 8, 2021. Crusader issued notices of non-renewal in accordance with the California Department of Insurance (“ CA DOI AAC
Principles Of Consolidation	The accompanying consolidated financial statements include the accounts of Unico American Corporation and its subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Basis Of Presentation	The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (“ GAAP
Going Concern	The Company prepared the accompanying consolidated financial statements on a going concern basis, which assumes that it will realize its assets and satisfy its liabilities in the normal course of business. Unico has a history of recurring losses from operations, and negative cash flows from its operating activities which may continue in the future, and, as a holding company, does not independently generate significant revenue and is dependent on dividends and other cash distributions from Crusader and its other subsidiaries to fund its operations and expenses. Historically, Unico generally received dividends periodically from Crusader, but does not expect to receive any such dividends for the foreseeable future due to prohibitions on dividends imposed by the CA DOI pursuant to the Supervision Agreement (the “ Supervision Agreement Special Examiner Based on Unico’s current cash, and short‑term investments at December 31, 2021, as well as the other factors described herein, there is substantial doubt that Unico will have sufficient cash to meet its operating and other liquidity requirements when they become due during the next twelve months from the date of issuance of the accompanying consolidated financial statements. Unico needs to improve its consolidated operating results, continue to receive financial support from Crusader, and/or raise substantial additional capital to continue to fund its operations. Unico has taken actions to cause Crusader to enter into runoff and to wind down operations that support the writing of insurance policies. To address its liquidity concerns and meet its capital obligations, Unico has announced a review of strategic alternatives and, with the assistance of a financial advisor, is considering multiple alternatives, including, but not limited to, strategic financing, further scaling back, or eliminating some or all of its remaining business operations, expense reductions, reorganization, merger with another entity, filing for bankruptcy or cessation of operations. There can be no assurances that capital will be available when needed or that, if available, it will be obtained on terms favorable to the Company and its stockholders, particularly in light of the effects that the coronavirus COVID-19 (“ COVID-19”
Use Of Estimates In The Preparation Of The Financial Statements	The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these consolidated financial statements relate to losses and loss adjustment expenses. Actual results may differ significantly from the estimates used in preparing the consolidated financial statements.
Supervision Agreement	Crusader and the CA DOI entered into the Supervision Agreement, dated September 7, 2021, at the request of the CA DOI. The Supervision Agreement was requested by the CA DOI because of the CA DOI’s expressed concerns regarding the financial stability of Crusader and the potential effects on Crusader and Crusader’s California policyholders of any potential bankruptcy of Unico. The Supervision Agreement among other things, provides for the appointment by the CA DOI of a Special Examiner to provide supervision and regulatory oversight of Crusader. The Supervision Agreement imposes limitations on Crusader’s ability to take certain actions without the prior written consent of the CA DOI Commissioner (the “ Commissioner On September 13, 2021, the Special Examiner advised Crusader, through its counsel, that a deficiency existed in certain funds that Unifax is required to maintain, in a fiduciary capacity, for Crusader's benefit. Pursuant to the provisions of California Insurance Code Sections ("CIC") Sections 1733 and 1734, Unifax is required to hold premium payment funds received from policyholders as fiduciary funds in trust maintained for the benefit of Crusader. The Special Examiner informed Crusader that the CA DOI believed that the deficiency in such fiduciary funds was approximately $3,100,000 as of September 13, 2021. As of September 30, 2021, the amount of such deficiency was $2,452,835. In January 2022 Unico, Crusader, and Unifax agreed, with the pre-approval of the Special Examiner, to transfer a computer system, owned by Unico, to Crusader. Unico contributed the computer system at its book value of $1,991,956, to Unifax, and Unifax in turn contributed the computer system to Crusader at its book value of $1,991,956 as a direct reduction in the amount due to Crusader which resulted in a dollar-for-dollar reduction in the premium trust deficiency. The amount of such deficiency was $275,901 as of March 31, 2022, and $432,900 as of May 31, 2022.
Independent Investigation	The Audit Committee of Unico’s Board of Directors retained independent outside counsel, who in turn engaged forensic accountants to work at their direction, to conduct an independent investigation and provide legal advice to the Audit Committee (the “ Independent Investigation
Investments	The Company’s fixed maturity investments are classified either as held-to-maturity or available-for-sale. Available-for-sale fixed maturity investments and are stated at fair value and held-to-maturity securities are stated at amortized cost. Although part of the Company's investments is classified as available‑for‑sale and the Company may sell investment securities from time to time in response to cash flow requirements, economic, regulatory, and/or market conditions or investment securities may be called by their issuers prior to the securities’ maturity, its investment guidelines place primary emphasis on buying and holding high‑quality investments to maturity. Short‑term investments are carried at cost, which approximates fair value. Equity securities are reported at fair value. The Company’s equity securities allocation is intended to enhance the return of and provide diversification for the total investment portfolio. The unrealized gains or losses from fixed maturities are reported as “Accumulated other comprehensive income (loss),” which is a separate component of stockholders’ equity, net of any deferred tax effect. The net unrealized investment gains on equity securities are reported in the Consolidated Statements of Operations. When a decline in the value of a fixed maturity is considered other-than-temporary, a loss is recognized in the Consolidated Statements of Operations. Realized gains and losses are included in the Consolidated Statements of Operations based on the specific identification method. The Company has a comprehensive portfolio monitoring process to identify and evaluate each fixed income security whose carrying value may be other-than-temporarily impaired. For each fixed income security in an unrealized loss position, the Company assesses whether it is more likely than not that the Company will be required to sell the security before recovery of the amortized cost basis for reasons such as liquidity, contractual or regulatory purposes, or the credit quality of the underlying security. If a security meets this criteria, the security's decline in fair value is considered other than temporary and is recorded as a net realized investment loss in the Consolidated Statements of Operations based on the specific identification method. There were no realized investments gains (losses) from other than temporary impairments for any of the periods presented in the accompanying Consolidated Statements of Operations. For each fixed income security that the Company does not intend to sell or for which it is more likely than not that the Company would not be required to sell before an anticipated recovery in value, the Company separates the credit loss component of the impairment, if any, from the amount related to all other factors and reports the credit loss component in net realized investment gains (losses). Short‑term investments include U.S. Treasury bills, certificates of deposit, and commercial paper that are all highly rated and have initial maturities between three and twelve months.
Fair Value Of Financial Instruments	The Company employs a fair value hierarchy that prioritizes the inputs for valuation techniques used to measure fair value. The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (the exit price). Financial assets and financial liabilities recorded on the Consolidated Balance Sheets at fair value are categorized based on the reliability of inputs to the valuation techniques. (See Note 5.) The Company has used the following methods and assumptions in estimating its fair value disclosures for instruments carried at fair value: · Available-for-sale fixed maturity securities, equity securities, and short-term investments – Fair values are obtained from widely accepted third party vendors. · Cash, cash equivalents, and restricted cash – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. · Long-term certificates of deposit – The carrying amounts reported in the Consolidated Balance Sheets for these instruments are at amortized cost which approximates their fair value. · Receivables, net – The carrying amounts reported in the Consolidated Balance Sheets approximate their fair values given the short-term nature of these instruments. · Accrued expenses and other liabilities – The carrying amounts reported in the Consolidated Balance Sheets approximate the fair values given the short-term nature of these instruments.
Property And Equipment	All property and equipment held for use is stated at cost less accumulated depreciation and amortization on the Consolidated Balance Sheets. Depreciation through the February 12, 2021 sale date on Crusader’s, previously owned building, located at 26050 Mureau Road, Calabasas, California, was computed using the straight-line method over 39 years. Improvements to the building structure were amortized over the useful life of the improvements. Depreciation on furniture, fixtures and equipment in the Calabasas building was computed using the straight-line method over 3 to 15 years. Amortization of tenant improvements in the Calabasas building was being computed using the shorter of the useful life of the tenant improvements or the remaining years of the lease. Refer to Note 6 regarding the sale of the building.
Income Taxes	The Company and its subsidiaries file consolidated federal and state income tax returns. Pursuant to the tax allocation agreement, Crusader and AAC are allocated taxes or tax credits in the case of losses, at current corporate rates based on their own taxable income or loss. The Company files income tax returns under U.S. federal and various state jurisdictions. The Company is subject to examination by U.S. federal income tax authorities for tax returns filed starting at taxable year 2018 and California state income tax authorities for tax returns filed starting at taxable year 2017. There are no ongoing examinations of income tax returns by federal or state tax authorities. As a California insurance company, Crusader is obligated to pay a premium tax on direct written premium in all states that Crusader is admitted. Premium taxes are deferred and amortized as the related premium is earned. The premium tax is in lieu of state franchise taxes and is not included in the provision for state taxes. The provision for federal income taxes is computed on the basis of income as reported for financial reporting purposes. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes and are measured using the enacted tax rates and laws expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Income tax expense provisions increase or decrease in the same period in which a change in tax rates is enacted. At each balance sheet date, management assesses the need to establish a valuation allowance that reduces deferred tax assets when it is more-likely-than-not that any portion of the deferred tax asset will not be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income of the appropriate character within the carryback and carryforward periods available under the tax law. Management considers the reversal of deferred tax liabilities, projected future taxable income of an appropriate nature and tax-planning strategies when making this assessment. In light of the net losses that were generated in recent years, as of December 31, 2021, the Company has established a valuation allowance for the aggregate amount of the federal and state net operating losses and other deferred tax assets in the amount of $11,939,459 that, in management’s judgment, are not more-likely-than-not to be realized. As of December 31, 2020, the Company carried a valuation allowance on deferred tax assets generated from federal and state net operating losses and other temporary differences in the amount of $10,557,080.
Earnings Per Share	Basic earnings per share exclude the impact of common share equivalents and are based upon the weighted average common shares outstanding. Diluted earnings per share utilize the average market price per share when applying the treasury stock method in determining common share dilution. When outstanding stock options are dilutive, they are treated as common share equivalents for purposes of computing diluted earnings per share and represent the difference between basic and diluted weighted average shares outstanding. In loss periods, the options are excluded from the calculation of diluted earnings per share, as the inclusion of such options would have an anti-dilutive effect.
Revenue Recognition	a. General Agency Operations Commissions from sales of health insurance are earned and recognized in income based on the satisfaction of a single performance obligation. Marketing, selling, billing, collecting, and administering health insurance policies are a series of distinct services combined as one performance obligation, which is recognized in income monthly over the policy period. Premiums are collected upon the initial sale of health insurance policies and then monthly upon each subsequent periodic payment. As a result, there are limited accounts receivable. Policy fee income is recognized on a pro-rata basis over the terms of the policies. b. Insurance Company Operation Premium is earned on a pro‑rata basis over the terms of the policies. Premium applicable to the unexpired terms of policies in force are recorded as unearned premium. c. Insurance Premium Financing Operations Premium finance interest may be charged to policyholders who choose to finance insurance premium. Interest is charged at rates that vary with the amount of premium financed. Premium finance interest, if any, is recognized using a method that approximates the interest (actuarial) method. Other charges and fees earned include late fees, returned check fees and payment processing fees that are earned when recorded.
Loss And Loss Adjustment Expenses	The liability for unpaid losses and loss adjustment expenses is based upon the accumulation of individual case estimates for losses reported prior to the close of the accounting period plus estimates based on experience and industry data for development of case estimates and for incurred but unreported losses and loss adjustment expenses. There is a high level of uncertainty inherent in the evaluation of the required loss and loss adjustment expense reserves for Crusader. The long-tailed nature of liability claims, and the volatility of jury awards exacerbate that uncertainty. Crusader records loss and loss adjustment expense reserves at each balance sheet date based upon management’s best estimate of the ultimate payments that it anticipates will be made to settle all losses incurred and related expenses incurred as of that date for both reported and unreported losses. The ultimate cost of claims is dependent upon future events, the outcomes of which are affected by many factors. Crusader’s claim reserving procedures and settlement philosophy, current and perceived social and economic inflation, current and future court rulings and jury attitudes, improvements in medical technology, and many other economic, scientific, legal, political, and social factors all can have significant effects on the ultimate costs of claims. Changes in Company operations and management philosophy also may cause actual developments to vary from the past. Since the emergence and disposition of claims are subject to uncertainties, the net amounts that will ultimately be paid to settle claims may vary significantly from the estimated amounts provided for in the accompanying consolidated financial statements. Any adjustments to reserves are reflected in the operating results of the periods in which they are made. Management believes that the aggregate reserves for losses and loss adjustment expenses are reasonable and adequate to cover the cost of claims, both reported and unreported. The Company applies judgment in determining estimates for reserves associated with anticipated recoveries of salvage and subrogation on paid losses and loss adjustment expenses based on its historic salvage and subrogation recovery success pattern.
Restricted Funds	Note 1 to the Company’s historical annual audited financial statements (“ Note 1 Premium Trust Account”); Restricted funds are as follows: Year ended December 31 2021 2020 (Revised) Premium trust funds (1)(2) $ 381,942 $ 1,210,243 Assigned to state agencies (3) 500,000 998,000 Funds held as collateral (4) 8,162,053 787,653 Total restricted funds $ 9,043,995 $ 2,995,896 (1) The Company is required by law to segregate from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. As disclosed in further detail in Note 1 above under “Supervision Agreement” and “Independent Investigation,” Unifax did not comply with the requirements of the California Insurance Code to hold such funds in separate accounts or segregate such funds in accordance with the CIC. (2) At December 31, 2020, there was a deficiency (the “Premium Trust Account Deficiency”) in the amount of funds required to be held in trust by Unifax for the benefit of Crusader. The amount of the Premium Trust Account Deficiency was $1,595,135 at December 31, 2020. The amount of the Premium Trust Account Deficiency was $2,172,968 as of December 31, 2021. (3) $300,000 and $798,000 included in fixed maturity investments as of December 31, 2021 and 2020, respectively, and $200,000 included in short-term investments as of December 31, 2021 and 2020, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California. (4) Funds held as collateral by Comerica Bank & Trust, N. A. (“Comerica”) pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance arrangement with USIC.
Deferred Policy Acquisition Costs	Policy acquisition costs consist of commissions, premium taxes, inspection fees, and certain other underwriting costs, which are related to the successful production of Crusader insurance policies. Policy acquisition costs that are eligible for deferral are deferred and amortized as the related premium is earned and are limited to their estimated realizable value based on the related unearned premium plus investment income less anticipated losses and loss adjustment expenses. Ceding commission applicable to the unexpired terms of policies in force is recorded as unearned ceding commission, which is included in deferred policy acquisition costs.
Reinsurance	Crusader employs reinsurance to provide greater diversification of business allowing management to control exposure to potential losses arising from large risks by reinsuring certain levels of risk in various areas of exposure, to reduce the loss that may arise from catastrophes, and to provide additional capacity for growth. Prepaid reinsurance premium and reinsurance receivables are reported as assets and represent ceded unearned premium and reinsurance recoverable on both paid and unpaid losses and loss adjustment expenses, respectively. Amounts recoverable from reinsurers are estimated in a manner consistent with the claim liability associated with the reinsured policies. Crusader evaluates each of its ceded reinsurance contracts at its inception to determine if there is sufficient risk transfer to allow the contract to be accounted for as reinsurance under current accounting literature. As of December 31, 2021, and 2020, all such ceded contracts are accounted for as risk transfer reinsurance. Crusader evaluates and monitors the financial condition of its reinsurers and factors such as collection periods, disputes, applicable coverage defenses and other factors to assess the need for any allowance against anticipated reinsurance recoveries. No such allowance was considered necessary at December 31, 2021 or 2020. Crusader’s reinsurance recoverable on paid and unpaid losses and loss adjustment expenses is as follows: Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2021 2020 Renaissance Reinsurance U.S. Inc. A+ $ 14,339,203 $ 11,906,416 Hannover Ruck SE A+ 13,433,710 10,673,173 TOA Reinsurance Company of America A 255,521 295,188 Other A (825 ) 172 Total $ 28,027,609 $ 22,874,949 (1) A.M. Best ratings are as of December 31, 2021.
Concentration Of Risk	100% and 99.9% respectively of Crusader’s gross written premium was derived from California during the years ended December 31, 2021 and 2020. In 2021, approximately 26% and 58% of the $732,852 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively. In 2020, approximately 30% and 56% of the $727,515 commission income from the Company’s health insurance program was from Guardian Life Insurance Company of America dental and group life plan programs and Blue Shield Care Trust health and life insurance programs, respectively.
Stock Based Compensation	Share-based compensation expense for all share-based payment awards is based on the grant-date fair value estimated in accordance with the provisions of ASC Topic 718, “Compensation - Stock Compensation” using the modified prospective transition method.
Recently adopted standards	In December of 2019, the FASB issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ ASU 2019-12
Standards not yet adopted	In June 2016, the FASB issued Accounting Standards Update No. ASU 2016-13, Measurement of Credit Losses on Financial Instruments, (“ ASU 2016-13

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies (Tables)
Schedule Of Restricted Funds	Year ended December 31 2021 2020 (Revised) Premium trust funds (1)(2) $ 381,942 $ 1,210,243 Assigned to state agencies (3) 500,000 998,000 Funds held as collateral (4) 8,162,053 787,653 Total restricted funds $ 9,043,995 $ 2,995,896
Reinsurance Recoverable On Paid And Unpaid Losses And Loss Adjustment Expenses	Year ended December 31 Name of Reinsurer A.M. Best Rating (1) 2021 2020 Renaissance Reinsurance U.S. Inc. A+ $ 14,339,203 $ 11,906,416 Hannover Ruck SE A+ 13,433,710 10,673,173 TOA Reinsurance Company of America A 255,521 295,188 Other A (825 ) 172 Total $ 28,027,609 $ 22,874,949

Cash, Restricted Cash and Cas_2

Cash, Restricted Cash and Cash Equivalents (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Cash, Restricted Cash And Cash Equivalents	December 31 2021 2020 (Revised) Cash and Cash Equivalents $ 15,244,709 $ 2,747,737 Restricted Cash 381,942 1,210,243 Total $ 15,626,651 $ 3,957,980

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2021
Investments (Tables)
Summary Of Investment Income And Net Realized Gains	December 31 2021 2020 Investment income: Fixed maturities $ 1,920,624 $ 2,068,592 Equity securities 90,596 28,727 Short-term investments and cash equivalents 2,660 24,603 Gross investment income 2,013,880 2,121,922 Less investment expenses (80,887 ) (133,679 ) Net investment income 1,932,993 1,988,243 Net realized investment gains 259,912 97,771 Net realized gain on sale of real estate 3,693,858 - Net unrealized investment gains on equity securities 400,862 198,266 Net investment income, realized investment gains, realized gains on real estate sale and unrealized investment gains $ 6,287,625 $ 2,284,280
Investments By Contractual Maturity	Maturities by Year at December 31, 2021 Amortized Cost Fair Value Weighted Average Yield Due in one year $ 15,758,755 $ 15,875,423 2.21 % Due after one year through five years 19,349,200 19,681,599 1.80 % Due after five years through ten years 19,335,034 19,832,093 2.39 % Due after ten years and beyond 17,075,416 17,324,290 2.35 % Total $ 71,518,405 $ 72,713,405 2.18 % Maturities by Year at December 31, 2020 Amortized Cost Fair Value Weighted Average Yield Due in one year $ 11,064,202 $ 11,169,232 2.57 % Due after one year through five years 30,090,910 31,260,694 2.59 % Due after five years through ten years 18,476,051 19,806,444 2.51 % Due after ten years and beyond 21,238,117 21,971,324 2.63 % Total $ 80,869,280 $ 84,207,694 2.58 %
Investments By Amortized Cost And Estimated Fair Value	Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value December 31, 2021 Available-for-sale fixed maturities: U.S. Treasury securities $ 6,278,764 $ 67,516 $ (36,475 ) $ 6,309,805 Corporate securities 44,370,193 1,076,288 (196,508 ) 45,249,973 Agency mortgage-backed securities 20,569,448 352,466 (68,287 ) 20,853,627 Held-to-maturity fixed maturities: Certificates of deposit 300,000 - - 300,000 Total fixed maturities $ 71,518,405 $ 1,496,270 $ (301,270 ) $ 72,713,405 December 31, 2020 Available-for-sale fixed maturities: U.S. Treasury securities $ 10,596,808 $ 235,373 $ - $ 10,832,181 Corporate securities 44,159,926 2,347,826 (55,847 ) 46,451,905 Agency mortgage-backed securities 25,314,546 833,336 (22,274 ) 26,125,608 Held-to-maturity fixed maturities: Certificates of deposit 798,000 - - 798,000 Total fixed maturities $ 80,869,280 $ 3,416,535 $ (78,121 ) $ 84,207,694
Summary of unrealized gains (losses) on investments	Year ended December 31 2021 2020 Gross unrealized gains of fixed maturities $ 1,496,270 $ 3,416,535 Gross unrealized losses of fixed maturities (301,270 ) (78,121 ) Net unrealized gains on investments 1,195,000 3,338,414 Deferred federal tax expense (250,950 ) (701,067 ) Net unrealized gains, net of deferred income taxes $ 944,050 $ 2,637,347
Components Of Investments In Unrealized Loss Position For Continuous Period Of Time	Less than 12 Months 12 Months or Longer Estimated Fair Value Gross Unrealized Losses Number of Securities Estimated Fair Value Gross Unrealized Losses Number of Securities December 31, 2021 U.S. Treasury securities $ 481,875 $ (15,785 ) 1 $ 476,016 $ (20,690 ) 1 Corporate securities 13,152,240 (128,502 ) 15 1,179,235 (68,006 ) 1 Agency mortgage-backed securities 5,086,187 (43,019 ) 8 471,479 (25,268 ) 1 Total debt securities 18,720,302 (187,306 ) 24 2,126,730 (113,964 ) 3 Equity securities 665,100 (55,156 ) 18 76,454 (4,703 ) 3 Total $ 19,385,402 $ (242,462 ) 42 $ 2,203,184 $ (118,667 ) 6 Less than 12 Months 12 Months or Longer Estimated Fair Value Gross Unrealized Losses Number of Securities Estimated Fair Value Gross Unrealized Losses Number of Securities December 31, 2020 U.S. Treasury securities $ - $ - - $ - $ - - Corporate securities 2,101,986 (55,847 ) 2 - - - Agency mortgage-backed securities 3,223,329 (22,274 ) 12 - - - Total debt securities 5,325,315 (78,121 ) 14 - - - Equity securities 723,346 (37,357 ) 25 - - - Total $ 6,048,661 $ (115,478 ) 39 $ - $ - -
Fixed Maturities Sold And Called	December 31 December 31 2021 2020 Fixed maturities securities sold Number of securities sold 3 15 Amortized cost of sold securities $ 2,194,103 $ 5,529,470 Realized gains on sales $ 710 $ 52,053 Fixed maturities securities called Number of securities called 10 4 Amortized cost of called securities $ 7,167,178 $ 2,449,503 Realized (losses) gains on calls $ (17,758 ) $ 497
Summary Of Equity Investments	December 31 December 31 2021 2020 Cost $ 3,532,026 $ 2,548,440 Unrealized gain 599,127 198,266 Fair market value of equity securities $ 4,131,153 $ 2,746,706
Summary Of State Held Deposits	Year ended December 31 2021 2020 Certificates of deposit $ 300,000 $ 200,000 Short-term investments 200,000 200,000 Total state held deposits $ 500,000 $ 400,000
Summary Of Short Term Investments	Year ended December 31 2021 2020 Short term bonds 954,750 - Certificates of deposit 200,000 200,000 Total short-term investments $ 1,154,750 $ 200,000

Fair Value Of Financial Instr_2

Fair Value Of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2021
Fair Value Of Financial Instruments (Tables)
Fair Value Of Financial Instruments	Level 1 Level 2 Level 3 Total December 31, 2021 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 6,309,805 $ - $ - $ 6,309,805 Corporate securities - 45,249,973 - 45,249,973 Agency mortgage-backed securities - 20,853,627 - 20,853,627 Held-to-maturity securities Certificates of deposits - 300,000 - 300,000 Equity securities 4,131,153 - - 4,131,153 Short-term investments 1,154,750 - - 1,154,750 Total financial instruments at fair value $ 11,595,708 $ 66,403,600 $ - $ 77,999,308 December 31, 2020 Financial instruments: Available-for-sale fixed maturities: U.S. Treasury securities $ 10,832,181 $ - $ - $ 10,832,181 Corporate securities - 46,451,905 - 46,451,905 Agency mortgage-backed securities - 26,125,608 - 26,125,608 Held-to-maturity securities Certificates of deposits - 798,000 - 798,000 Equity securities 2,746,706 - - 2,746,706 Short-term investments 200,000 - - 200,000 Total financial instruments at fair value $ 13,778,887 $ 73,375,513 $ - $ 87,154,400

Real Estate Held for Sale, Ne_2

Real Estate Held for Sale, Net and Property and Equipment, Net (Tables)	12 Months Ended
	Dec. 31, 2021
Real Estate Held for Sale, Net and Property and Equipment, Net (Tables)
Real Estate Held For Sale, Net And Property And Equipment, Net	Year ended December 31 2021 2020 Real estate held for sale, located in Calabasas, California $ - $ 10,202,676 Accumulated depreciation and amortization - (1,867,659 ) Real estate held for sale, net $ - $ 8,335,017 Year ended December 31 2021 2020 Furniture, fixtures, equipment 2,316,885 2,191,411 Computer software 466,892 467,275 Accumulated depreciation and amortization (2,983,418 ) (2,423,617 ) Computer software under development 2,354,161 1,803,346 Property and equipment, net $ 2,154,520 $ 2,038,415

Receivables, net (Tables)

Receivables, net (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Receivables, Net	December 31 2021 2020 Premium and commission receivable $ 672,284 $ 2,476,679 Premium finance notes receivable 755,691 2,036,960 Total premium and notes receivable 1,427,975 4,513,639 Allowance for doubtful accounts (223,962 ) (1,192,302 ) Receivables, net $ 1,204,013 $ 3,321,337

Unpaid Losses and Loss Adjust_2

Unpaid Losses and Loss Adjustment Expenses (Tables)	12 Months Ended
	Dec. 31, 2021
Unpaid Losses and Loss Adjustment Expenses (Tables)
Unpaid Losses And Loss Adjustment Expense	December 31 2021 2020 Gross reserves: Case reserves $ 29,293,117 $ 26,363,695 IBNR reserves 53,199,557 48,529,814 Total gross reserves $ 82,492,674 $ 74,893,509 Reserves net of reinsurance: Case reserves $ 23,057,464 $ 21,027,703 IBNR reserves 32,319,167 31,612,164 Total net reserves $ 55,376,631 $ 52,639,867
Reserves For Loss And Loss Adjustment Expenses By Line Of Business	Year ended December 31 Line of Business 2021 2020 CMP $ 81,303,803 98.5 % $ 73,545,181 98.2 % Other liability 1,122,823 1.4 % 1,283,174 1.7 % Other 66,048 0.1 % 65,154 0.1 % Total $ 82,492,674 100.0 % $ 74,893,509 100.0 %
Rollforward Of Loss And Loss Adjustment Expense Reserves	Year ended December 31 2021 2020 Reserve for unpaid losses and loss adjustment expenses at beginning of year – net of reinsurance $ 52,639,867 $ 40,340,625 Incurred losses and loss adjustment expenses: Provision for insured events of current year 26,097,435 26,683,872 Provision for insured events of prior years (124,595 ) 7,959,048 Total incurred losses and loss adjustment expenses 25,972,840 34,642,920 Payments: Losses and loss adjustment expenses attributable to insured events of the current year 8,007,546 8,285,021 Losses and loss adjustment expenses attributable to insured events of prior years 15,228,530 14,058,657 Total payments 23,236,076 22,343,678 Reserve for unpaid losses and loss adjustment expenses at end of year – net of reinsurance 55,376,631 52,639,867 Reinsurance recoverable on unpaid losses and loss adjustment expenses at end of year 27,116,043 22,253,642 Reserve for unpaid losses and loss adjustment expenses at end of year per balance sheet, gross of reinsurance $ 82,492,674 $ 74,893,509
Incurred but not reported liabilities and incurred paid claim development	Accident Year Cumulative Incurred Cumulative Paid Total of Incurred but Not Reported Liabilities Plus Expected Development on Reported Claims Cumulative Number of Reported Claims 2012 18,353,966 18,355,881 - 967 2013 22,852,457 22,849,314 (2 ) 850 2014 17,965,556 17,817,189 (108,710 ) 760 2015 25,332,806 23,197,570 (525,502 ) 749 2016 27,006,706 24,528,218 (1,584,393 ) 808 2017 26,103,135 21,188,239 (2,301,034 ) 825 2018 19,179,716 13,750,695 (3,465,021 ) 614 2019 18,723,515 10,898,586 (5,558,880 ) 648 2020 22,611,110 9,769,654 (6,518,530 ) 771 2021 23,198,334 5,027,785 (11,452,987 ) 626 Total $ 221,327,301 $ 167,383,131 $ (31,515,059 )
Reconciliation Of Cumulative Incurred And Paid Claims To Unpaid Losses And Loss Adjustment Expenses	Year ended December 31 2021 2020 Cumulative incurred losses and ALAE $ 221,327,301 $ 218,410,701 Less cumulative paid losses and ALAE (167,383,131 ) (167,214,395 ) Reserve for unpaid losses and ALAE (latest 10 accident years) 53,944,170 51,196,306 Reserves for unpaid losses and ALAE (beyond latest 10 accident years) 68,604 79,703 Reserves for unpaid unallocated loss adjustment expenses 1,363,857 1,363,858 Reserve for unpaid losses and loss adjustment expenses, net of reinsurance 55,376,631 52,639,867 Reinsurance recoverable on unpaid losses and loss adjustment expenses 27,116,043 22,253,642 Reserve for unpaid losses and loss adjustment expenses, gross of reinsurance $ 82,492,674 $ 74,893,509

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs (Tables)	12 Months Ended
	Dec. 31, 2021
Deferred Policy Acquisition Costs (Tables)
Deferred Policy Acquisition Costs Rollforward	Year ended December 31 2021 2020 Deferred policy acquisition costs at beginning of year $ 3,503,248 $ 3,619,594 Policy acquisition costs deferred during year 2,926,203 4,782,461 Policy acquisition costs amortized during year (5,442,645 ) (4,898,807 ) Deferred policy acquisition costs at end of year $ 986,806 $ 3,503,248

Accrued Expenses and Other Liab

Accrued Expenses and Other Liabilities (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Accrued Expenses And Other Liabilities	Year ended December 31 2021 2020 Premium payable $ 508,147 $ 393,466 Unearned policy fee income 224,536 454,883 Retirement plans 12,413 145,473 Accrued salaries and employee benefits 53,449 973,504 Commission payable (251 ) 869 Security deposit for Calabasas Building sale - 380,850 Other 1,467,943 1,228,405 Total accrued expenses and other liabilities $ 2,266,237 $ 3,577,450

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2021
Reinsurance (Tables)
Primary Reinsurance Agreements	Loss Year Reinsurers A.M. Best Rating Retention 2021 Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE A+ A+ $ 500,000 2020 Renaissance Reinsurance U.S. Inc. & Hannover Ruck SE A+ A+ $ 500,000
Effect Of Reinsurance On Premiums Written, Premiums Earned, And Incurred Losses	Year ended December 31 2021 2020 Written premium: Direct $ 32,871,625 $ 36,338,800 Assumed 3,395,010 304,030 Ceded (11,551,580 ) (8,078,748 ) Net written premium $ 24,715,055 $ 28,564,082 Earned premium: Direct $ 38,278,730 $ 36,108,230 Assumed 1,844,931 156,639 Ceded (11,693,756 ) (8,096,701 ) Net earned premium $ 28,429,905 $ 28,168,168 Year ended December 31 2021 2020 Incurred losses and loss adjustment expenses: Direct $ 35,218,127 $ 48,971,172 Assumed 836,622 89,204 Ceded (10,081,909 ) (14,417,456 ) Net incurred losses and loss adjustment expenses $ 25,972,840 $ 34,642,920

Profit Sharing Plan (Tables)

Profit Sharing Plan (Tables)	12 Months Ended
	Dec. 31, 2021
Profit Sharing Plan (Tables)
Profit Sharing Plan Expenses	Year ended December 31, 2021 $ 171,205 Year ended December 31, 2020 $ 154,331

Statutory Capital and Surplus (

Statutory Capital and Surplus (Tables)	12 Months Ended
	Dec. 31, 2021
Statutory Capital and Surplus (Tables)
Statutory Capital And Surplus	As of December 31, 2021 $ 22,494,454 As of December 31, 2020 $ 26,893,515
Statutory Net Loss	Year ended December 31, 2021 $ (1,774,020 ) Year ended December 31, 2020 $ (12,862,588 )

Stock Plans (Tables)

Stock Plans (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Assumptions Used	Weighted-average grant date fair value $ 4.52 Expected dividend yield 0.00 % Expected volatility 96.35 % Risk-free interest rate 0.09 % Expected term (years) 4.00 Expected forfeiture 50.00 %
Summarizes Non-qualified Stock Option And Restricted Stock Grants Activity	Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Terms Aggregate Intrinsic Value Outstanding at December 31, 2020 - - - - Non-qualified stock option granted 14,250 $ 4.52 4.00 - Restricted stock granted 17,000 4.52 4.00 - Forfeited or expired (61,000 ) 4.52 - - Exercised - - - - Outstanding at December 31, 2021 31,250 $ 4.52 3.79 - Exercisable at December 31, 2021 - - - -

Taxes on Income (Tables)

Taxes on Income (Tables)	12 Months Ended
	Dec. 31, 2021
Taxes on Income (Tables)
Provision For Taxes	Year ended December 31 2021 2020 Federal expense Deferred 450,117 3,566,840 Total tax expense $ 450,117 $ 3,566,840 State expense Current $ 8,800 $ 8,800 Deferred - (28,042 ) Total tax expense (benefit) $ 8,800 $ (19,242 ) Total expense Current $ 8,800 $ 8,800 Deferred 450,117 3,538,798 Total tax expense $ 458,917 $ 3,547,598
Reconcilation of income tax provision reflected in the consolidated statements of operations and expected income tax	Year ended December 31 2021 2020 Computed income tax benefit at 21% $ (1,095,010 ) $ (3,768,138 ) Tax effect of: State tax expense (benefit), net of federal tax benefit 137,312 (572,511 ) Change in valuation allowance – state net operating losses (130,360 ) 557,310 Change in valuation allowance – federal 1,547,392 7,319,959 Other, including nondeductible expenses 3,620 10,920 Other – prior year true up (4,037 ) 58 Income tax expense $ 458,917 $ 3,547,598
Components Of Net Deferred Tax Assets	Year ended December 31 2021 2020 Deferred tax assets: Discount on loss reserves $ 605,164 $ 531,845 Unearned premium 599,571 759,659 Unearned commission income - 438,574 Unearned policy fee income 62,834 127,293 Net operating loss carryforwards 8,584,487 7,769,603 State net operating loss carryforwards 2,509,115 2,402,438 Unrealized losses on investments - - Bad debt reserve 62,673 333,649 Other 474,854 237,803 Total gross deferred tax assets 12,898,698 12,600,864 Less valuation allowance 11,939,459 10,557,080 Total deferred tax assets $ 959,239 $ 2,043,784 Deferred tax liabilities: Policy acquisition costs $ 191,586 $ 858,705 State tax on undistributed insurance company earnings 25,357 84,219 Federal tax liability on state deferred tax assets 63,456 91,277 Depreciation and amortization 302,073 266,880 Unrealized gains on investments 376,767 742,703 Total deferred tax liabilities $ 959,239 $ 2,043,784 Net deferred tax assets $ - $ -

Repurchase of Common Stock-Ef_2

Repurchase of Common Stock-Effect on Stockholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2021
Repurchase of Common Stock-Effect on Stockholders' Equity (Tables)
Common Stock Repurchase	December 31 December 31 2021 2020 2020 Program Number of shares repurchased 22 857 Cost of shares repurchased Allocated to retained earnings $ 91 $ 4,071 Allocated to capital 10 422 Total cost of shares repurchased $ 101 $ 4,493 2008 Program Number of shares repurchased - 978 Cost of shares repurchased Allocated to retained earnings - $ 5,760 Allocated to capital - 480 Total cost of shares repurchased $ - $ 6,240

Loss Per Share (Tables)

Loss Per Share (Tables)	12 Months Ended
	Dec. 31, 2021
Loss Per Share (Tables)
Basic And Diluted Earnings Per Share Calculation Data	Year ended December 31 2021 2020 Basic Loss Per Share Net loss numerator $ (5,673,251 ) $ (21,491,113 ) Weighted average shares outstanding denominator 5,304,872 5,305,829 Per share amount $ (1.07 ) $ (4.05 ) Diluted Loss Per Share Net loss numerator $ (5,673,251 ) $ (21,491,113 ) Weighted average shares outstanding 5,304,872 5,305,829 Effect of diluted securities - - Diluted shares outstanding denominator 5,304,872 5,305,829 Per share amount $ (1.07 ) $ (4.05 )

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Dec. 31, 2021
Accumulated Other Comprehensive Income
Components Of Accumulated Other Comprehensive Income	Pre-Tax Amount Tax (Expense) Benefit Net-of-Tax Amount December 31, 2020 $ 3,338,414 $ (701,067 ) $ 2,637,347 Changes in unrealized loss on available-for-sale securities (2,025,511 ) 425,357 $ (1,600,154 ) Reclassification adjustment for gains included in net loss (117,903 ) 24,760 $ (93,143 ) December 31, 2021 $ 1,195,000 $ (250,950 ) $ 944,050 December 31, 2019 $ 1,497,299 $ (314,433 ) $ 1,182,866 Changes in net unrealized gain on investments 1,905,367 (400,127 ) $ 1,505,240 Reclassification adjustment for net realized gains included in net loss (642,524 ) 13,493 $ (50,760 ) December 31, 2020 $ 3,338,413 $ (701,067 ) $ 2,637,347

Selected Quarterly Financial _2

Selected Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2021
Selected Quarterly Financial Data (Unaudited) (Tables)
Selected Quarterly Unaudited Financial Data	Comparable Period by Quarter Ended March 31 June 30 September 30 December 31 Calendar Year 2021 Total revenues $ 11,471,654 $ 8,132,605 $ 8,595,648 $ 8,188,477 Income (loss) before taxes $ 2,542,339 $ (1,430,835 ) $ (2,450,619 ) $ (3,875,219 ) Net income (loss) $ 2,267,703 $ (1,406,811 ) $ (2,510,198 ) $ (4,023,945 ) Income (loss) per share: Basic and Diluted $ 0.43 $ (0.27 ) $ (0.47 ) $ (0.76 ) Calendar Year 2020 Total revenues $ 8,005,181 $ 7,976,227 $ 8,259,686 $ 8,319,017 Loss before taxes $ (1,145,498 ) $ (384,562 ) $ (14,345,916 ) $ (2,067,539 ) Net loss $ (1,043,826 ) $ (434,814 ) $ (17,940,488 ) $ (2,071,985 ) Loss per share: Basic and Diluted $ (0.20 ) $ (0.08 ) $ (3.38 ) $ (0.39 )

Supplementary Information on _2

Supplementary Information on Loss and ALAE Development (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2021
Summary of Significant Accounting Policies
Cumulative Incurred Loss And Alae Development (tables)	Accident Year 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021 2012 $ 18,511,598 19,532,022 18,895,666 18,344,175 18,050,131 17,914,837 18,235,335 18,355,031 18,327,346 18,353,966 2013 $ 19,570,946 20,118,343 20,323,841 21,742,580 22,798,398 22,397,394 22,859,132 22,802,931 22,852,457 2014 $ 16,884,731 15,394,995 14,930,960 17,640,211 18,034,749 17,898,306 18,048,285 17,965,556 2015 $ 20,452,199 20,840,034 22,471,512 21,707,615 23,006,844 24,495,614 25,332,806 2016 $ 21,646,663 22,908,016 24,126,775 25,677,378 26,337,621 27,006,706 2017 $ 21,914,736 23,453,130 23,876,588 25,091,934 26,103,135 2018 $ 19,048,233 18,099,500 20,670,880 19,179,716 2019 $ 17,349,941 19,182,851 18,723,515 2020 $ 24,302,958 22,611,110 2021 $ 23,198,334
Cumulative Paid Loss And Alae Development (tables)	Year 2012 (1) 2013 (1) 2014 (1) 2015 (1) 2016 (1) 2017 (1) 2018 (1) 2019 (1) 2020 (1) 2021(1) 2012 $ 6,719,982 $ 11,673,621 13,411,125 15,369,629 16,734,967 17,265,513 17,638,646 18,001,581 18,020,565 18,355,881 2013 $ 7,594,731 10,656,777 14,319,057 19,067,334 21,415,490 21,875,978 22,364,215 22,802,275 22,849,314 2014 $ 3,826,263 6,082,893 9,173,947 14,556,687 16,843,128 17,487,722 17,806,537 17,817,189 2015 $ 6,263,796 11,151,955 14,978,639 17,700,688 20,148,880 21,502,400 23,197,570 2016 $ 7,435,120 12,009,273 15,916,432 21,438,785 23,326,143 24,528,218 2017 $ 6,405,641 11,503,228 15,289,400 18,869,369 21,188,239 2018 $ 4,959,689 9,254,754 12,129,118 13,750,695 2019 $ 4,292,275 7,603,418 10,898,586 2020 $ 6,004,292 9,769,654 2021 $ 5,027,785

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies
Premium Trust Funds	$ 381,942	$ 1,210,243
Assigned To State Agencies	500,000	998,000
Funds Held As Collateral	8,162,053	787,653
Total Restricted Funds	$ 9,043,995	$ 2,995,896

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reinsurance Recoverables	$ 28,027,609	$ 22,874,949
Renaissance Reinsurance U.S., Inc.
Reinsurance Recoverables	$ 14,339,203	$ 11,906,416
A.m. Best Rating	A+	A+
Hannover Rusk SE
Reinsurance Recoverables	$ 13,433,710	$ 10,673,173
A.m. Best Rating	A+	A+
TOA Reinsurance Company of America
Reinsurance Recoverables	$ 255,521	$ 295,188
A.m. Best Rating	A
Other
Reinsurance Recoverables	$ 825	$ 172
A.m. Best Rating	A

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		12 Months Ended
	Sep. 10, 2021	Dec. 31, 2021	Dec. 31, 2020	May 31, 2022	Mar. 31, 2022	Sep. 30, 2021	Sep. 13, 2021
Premium Trust Deficiency					$ 275,901	$ 2,452,835
Fiduciary Funds							$ 3,100,000
Gross Written Premium		100%	99.90%
Aggregate Payments	$ 20,000
Individual Payment	5,000
Incurring Debt, Obligation	5,000
Deferred Tax Asset Valuation Allowance On Federal Tax Loss Carryforward		$ 11,939,459	$ 10,557,080
Premium Trust Funds Deficiancy		2,172,968	1,595,135
Fixed Maturity Investments		300,000	798,000
Book Value Of Computer		$ 466,892	$ 467,275
Building [Member]
Property Plant And Equipment Useful Life, In Years		39 years
Supervision Agreement [Member]
Aggregate Payments	20,000
Individual Payment	$ 5,000
Maximums [Member] | Furniture and Fixtures [Member]
Property Plant And Equipment Useful Life, In Years		15 years
Minimums [Member] | Furniture and Fixtures [Member]
Property Plant And Equipment Useful Life, In Years		3 years
Customer 1 [Member]
Percentage of commission income		26%	30%
Customer 3 [Member]
Commission income		$ 732,852	$ 727,515
Customer 2 [Member]
Percentage of commission income		58%	56%
Subsequent Event [Member]
Premium Trust Account Deficiency				$ 432,900
Revision of Prior Period, Error Correction, Adjustment [Member]
Statutory Deposit Assigned To California State Treasurer		$ 200,000	$ 0
Statutory Deposit Held By Insurance Commission Of State Of Nevada		$ 200,000	$ 0
Unico [Member]
Book Value Of Computer						1,991,956
Unifax [Member]
Book Value Of Computer						$ 1,991,956

Cash, Restricted Cash and Cas_3

Cash, Restricted Cash and Cash Equivalents (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies
Cash	$ 15,244,709	$ 2,747,737
Restricted Cash	381,942	1,210,243
Cash Equivalents	$ 15,626,651	$ 3,957,980

Investments (Details)

Investments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Less Investment Expenses	$ (80,887)	$ (133,679)
Gross Investment Income	2,013,880	2,121,922
Net Investment Income	1,932,993	1,988,243
Net Realized Investment Gains	259,912	97,771
Net Realized Gains On Real Estate Sale	3,693,858	0
Net Unrealized Investment Gains On Equity Securities	400,862	198,266
Net Investment Income, Realized Invesetment Gains (losses), And Unrealized Investment Gains On Equity Securities	6,287,625	2,284,280
Fixed Maturities
Gross Investment Income	1,920,624	2,068,592
Equity Securities [Member]
Gross Investment Income	90,596	28,727
Short-Term Investments and Cash Equivalents [Member]
Gross Investment Income	$ 2,660	$ 24,603

Investments (Details 1)

Investments (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Fixed Maturity Investments, Amortized Cost	$ 71,518,405	$ 80,869,280
Fixed Maturity Investments, Fair Value	$ 72,713,405	$ 84,207,694
Fixed Maturity Investments, Weighted Average Yield	2.18%	2.58%
Due in one year
Fixed Maturity Investments, Amortized Cost	$ 15,758,755	$ 11,064,202
Fixed Maturity Investments, Fair Value	$ 15,875,423	$ 11,169,232
Fixed Maturity Investments, Weighted Average Yield	2.21%	2.57%
Due after one year through five years
Fixed Maturity Investments, Amortized Cost	$ 19,349,200	$ 30,090,910
Fixed Maturity Investments, Fair Value	$ 19,681,599	$ 31,260,694
Fixed Maturity Investments, Weighted Average Yield	1.80%	2.59%
Due after five years through ten years
Fixed Maturity Investments, Amortized Cost	$ 19,335,034	$ 18,476,051
Fixed Maturity Investments, Fair Value	$ 19,832,093	$ 19,806,444
Fixed Maturity Investments, Weighted Average Yield	2.39%	2.51%
Due after ten years and beyond
Fixed Maturity Investments, Amortized Cost	$ 17,075,416	$ 21,238,117
Fixed Maturity Investments, Fair Value	$ 17,324,290	$ 21,971,324
Fixed Maturity Investments, Weighted Average Yield	2.35%	2.63%

Investments (Details 2)

Investments (Details 2) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Amortized Cost, Fixed Maturities, Available For Sale	$ 71,218,405	$ 80,071,280
Estimated Fair Value, Fixed Maturities, Available For Sale	72,413,405	83,409,694
Amortized Cost, Fixed Maturities, Held To Maturity	300,000	798,000
Estimated Fair Value, Fixed Maturities, Held To Maturity	300,000	798,000
U.S. Treasury Securities [Member]
Amortized Cost, Fixed Maturities, Available For Sale	6,278,764	10,596,808
Gross Unrealized Gains, Fixed Maturities, Available For Sale	67,516	235,373
Gross Unrealized Losses, Fixed Maturities, Available For Sale	(36,475)	0
Estimated Fair Value, Fixed Maturities, Available For Sale	6,309,805	10,832,181
Corporate Securities [Member]
Amortized Cost, Fixed Maturities, Available For Sale	44,370,193	44,159,926
Gross Unrealized Gains, Fixed Maturities, Available For Sale	1,076,288	2,347,826
Gross Unrealized Losses, Fixed Maturities, Available For Sale	(196,508)	(55,847)
Estimated Fair Value, Fixed Maturities, Available For Sale	45,249,973	46,451,905
Agency Mortgage-Backed Securities [Member]
Amortized Cost, Fixed Maturities, Available For Sale	20,569,448	25,314,546
Gross Unrealized Gains, Fixed Maturities, Available For Sale	352,466	833,336
Gross Unrealized Losses, Fixed Maturities, Available For Sale	(68,287)	(22,274)
Estimated Fair Value, Fixed Maturities, Available For Sale	20,853,627	26,125,608
Total fixed maturities [Member]
Gross Unrealized Gains, Fixed Maturities, Available For Sale	1,496,270	3,416,535
Gross Unrealized Losses, Fixed Maturities, Available For Sale	(301,270)	(78,121)
Amortized Cost, Fixed Maturities, Available For Sale And Held-to-maturity Fixed Maturities	71,518,405	80,869,280
Estimated Fair Value, Fixed Maturities, Available For Sale And Held-to-maturity Fixed Maturities	72,713,405	84,207,694
Certificates of Deposit [Member]
Amortized Cost, Fixed Maturities, Held To Maturity	300,000	798,000
Gross Unrealized Gains, Fixed Maturities, Held To Maturity	0	0
Gross Unrealized Losses, Fixed Maturities, Held To Maturity	0	0
Estimated Fair Value, Fixed Maturities, Held To Maturity	$ 300,000	$ 798,000

Investments (Details 3)

Investments (Details 3) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Investments:
Gross Unrealized Gains On Fixed Maturities	$ 1,496,270	$ 3,416,535
Gross Unrealized Losses On Fixed Maturities	(301,270)	(78,121)
Net Unrealized Gains On Fixed Maturities	1,195,000	3,338,414
Deferred Federal Tax Expense	(250,950)	(701,067)
Net Unrealized Gains, Net Of Deferred Income Taxes	$ 944,050	$ 2,637,347

Investments (Details 4)

Investments (Details 4)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Gross Unrealized Losses, Less Than 12 Months	$ (242,462)	$ (115,478)
Number Of Securities In Unrealized Loss Positions For Less Than 12 Months	42	39
Fair Value, 12 Months Or Longer	$ 2,203,184	$ 0
Gross Unrealized Losses, 12 Months Or Longer	$ (118,667)	$ 0
Number Of Securities In Unrealized Loss Positions For 12 Months Or Longer	6	0
Fair Value, Less Than 12 Months	$ 19,385,402	$ 6,048,661
Equity Securities [Member]
Gross Unrealized Losses, Less Than 12 Months	$ (55,156)	$ (37,357)
Number Of Securities In Unrealized Loss Positions For Less Than 12 Months	18	25
Fair Value, 12 Months Or Longer	$ 76,454	$ 0
Gross Unrealized Losses, 12 Months Or Longer	$ (4,703)	$ 0
Number Of Securities In Unrealized Loss Positions For 12 Months Or Longer	3	0
Fair Value, Less Than 12 Months	$ 665,100	$ 723,346
U.S. Treasury Securities [Member]
Gross Unrealized Losses, Less Than 12 Months	$ (15,785)	$ 0
Number Of Securities In Unrealized Loss Positions For Less Than 12 Months	1	0
Fair Value, 12 Months Or Longer	$ 476,016	$ 0
Gross Unrealized Losses, 12 Months Or Longer	$ (20,690)	$ 0
Number Of Securities In Unrealized Loss Positions For 12 Months Or Longer	1	0
Fair Value, Less Than 12 Months	$ 481,875	$ 0
Corporate Securities [Member]
Gross Unrealized Losses, Less Than 12 Months	$ (128,502)	$ (55,847)
Number Of Securities In Unrealized Loss Positions For Less Than 12 Months	15	2
Fair Value, 12 Months Or Longer	$ 1,179,235	$ 0
Gross Unrealized Losses, 12 Months Or Longer	$ (68,006)	$ 0
Number Of Securities In Unrealized Loss Positions For 12 Months Or Longer	1	0
Fair Value, Less Than 12 Months	$ 13,152,240	$ 2,101,986
Agency Mortgage-Backed Securities [Member]
Gross Unrealized Losses, Less Than 12 Months	$ (43,019)	$ (22,274)
Number Of Securities In Unrealized Loss Positions For Less Than 12 Months	8	12
Fair Value, 12 Months Or Longer	$ 471,479	$ 0
Gross Unrealized Losses, 12 Months Or Longer	$ (25,268)	$ 0
Number Of Securities In Unrealized Loss Positions For 12 Months Or Longer	1	0
Fair Value, Less Than 12 Months	$ 5,086,187	$ 3,223,329
Debt Securities
Gross Unrealized Losses, Less Than 12 Months	$ (187,306)	$ (78,121)
Number Of Securities In Unrealized Loss Positions For Less Than 12 Months	24	14
Fair Value, 12 Months Or Longer	$ 2,126,730	$ 0
Gross Unrealized Losses, 12 Months Or Longer	$ (113,964)	$ 0
Number Of Securities In Unrealized Loss Positions For 12 Months Or Longer	3	0
Fair Value, Less Than 12 Months	$ 18,720,302	$ 5,325,315

Investments (Details 5)

Investments (Details 5)	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Investments:
Sold Securities - Number	3	15
Sold Securities - Amortized Cost	$ 2,194,103	$ 5,529,470
Sold Securities - Realized Gain (loss)	$ 710	$ 52,053
Called Securities - Number	10	4
Called Securities - Amortized Cost	$ 7,167,178	$ 2,449,503
Called Securities - Realized Gain (loss)	$ (17,758)	$ 497

Investments (Details 6)

Investments (Details 6) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Investments:
Cost	$ 3,532,026	$ 2,548,440
Unrealized Gain	599,127	198,266
Equity Securities	$ 4,131,153	$ 2,746,706

Investments (Details 7)

Investments (Details 7) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Investments:
Certificates Of Deposit	$ 300,000	$ 200,000
Short-term Investments	200,000	200,000
Total State Held Deposits	$ 500,000	$ 400,000

Investments (Details 8)

Investments (Details 8) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Investments:
Short-term Bonds	$ 954,750	$ 0
Certificates Of Deposit	200,000	200,000
Short-term Investments	$ 1,154,750	$ 200,000

Investments (Details Narrative)

Investments (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Investments:
Security Pledged As Collateral, Fair Value	$ 8,243,758	$ 824,500
Security Pledged As Collateral, Cost	$ 8,162,053	$ 787,653
Investment Maturity Period	6.7	8.0
Brokered Certificates Of Deposit	$ 300,000	$ 798,000

Fair Value of Financial Instr_3

Fair Value of Financial Instruments Fair Value of Invested Assets (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
U.s. Treasury Securities	$ 6,309,805	$ 10,832,181
Agency Mortgage-backed Securities	20,853,627	26,125,608
Corporate Securities	45,249,973	46,451,905
Certificates Of Deposits	300,000	798,000
Equity Securities	4,131,153	2,746,706
Short-term Investments	1,154,750	200,000
Total Financial Instruments	77,999,308	87,154,400
Level 1
U.s. Treasury Securities	6,309,805	10,832,181
Agency Mortgage-backed Securities	0	0
Corporate Securities	0	0
Certificates Of Deposits	0	0
Equity Securities	4,131,153	2,746,706
Short-term Investments	1,154,750	200,000
Total Financial Instruments	11,595,708	13,778,887
Level 2
U.s. Treasury Securities		0
Agency Mortgage-backed Securities	20,853,627	26,125,608
Corporate Securities	45,249,973	46,451,905
Certificates Of Deposits	300,000	798,000
Equity Securities	0	0
Short-term Investments	0	0
Total Financial Instruments	66,403,600	73,375,513
Level 3
U.s. Treasury Securities	0	0
Agency Mortgage-backed Securities	0	0
Corporate Securities	0	0
Certificates Of Deposits	0	0
Equity Securities	0	0
Short-term Investments	0	0
Total Financial Instruments	$ 0	$ 0

Real Estate Held for Sale, Ne_3

Real Estate Held for Sale, Net and Property and Equipment, Net (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Real Estate Held for Sale, Net and Property and Equipment, Net (Details)
Accumulated Depreciation On Real Estate Held For Sale	$ 0	$ (1,867,659)
Real Estate Held For Sale, Gross	0	10,202,676
Real Estate Held For Sale	0	8,335,017
Furniture, Fixtures, Equipment And Other Leasehold Improvements	2,316,885	2,191,411
Computer Software Under Development	466,892	467,275
Accumulated Depreciation And Amortization	(2,983,418)	(2,423,617)
Computer Software Under Development	2,354,161	1,803,346
Net Property And Equipment	$ 2,154,520	$ 2,038,415

Real Estate Held for Sale, Ne_4

Real Estate Held for Sale, Net and Property and Equipment, Net (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2021	Dec. 31, 2020	Feb. 12, 2021
Real Estate Held for Sale, Net and Property and Equipment, Net (Details Narrative)
Employees cost	$ 1,500,000
Total Cost	$ 2,326,811
Real Estate Selling Price				$ 12,695,000
Net Proceeds				12,028,876
Gain On Sale Of Building				3,693,858
Initial Rent				$ 56,963
Depreciation And Amortization On All Property And Equipment		$ 569,801	$ 673,895
Office Building Revenue From Leases To Non-affiliated Tenants		13,806	150,319
Office Building Expenses Including Depreciation		$ 235,827	$ 677,930

Receivables, Net (Details)

Receivables, Net (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies
Premium And Commission Receivable	$ 672,284	$ 2,476,679
Premium Finance Notes Receivable	755,691	2,036,960
Total Premium And Notes Receivable	1,427,975	4,513,639
Allowance For Doubtful Accounts	(223,962)	(1,192,302)
Net Receivables	$ 1,204,013	$ 3,321,337

Receivables, Net (Details Narra

Receivables, Net (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Summary of Significant Accounting Policies
Bad Debt Expense (benefit)	$ 6,451	$ 6,451
Bad Debt Recoveries	$ 167,532

Unpaid Losses and Loss Adjust_3

Unpaid Losses and Loss Adjustment Expenses (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Unpaid Losses and Loss Adjustment Expenses (Details)
Gross Case Reserves	$ 29,293,117	$ 26,363,695
Gross Ibnr Reserves	53,199,557	48,529,814
Total Gross Reserves	82,492,674	74,893,509
Reserves Net Of Reinsurance
Net Case Reserves	23,057,464	21,027,703
Net Ibnr Reserves	32,319,167	31,612,164
Total Net Reserves	$ 55,376,631	$ 52,639,867

Unpaid Losses and Loss Adjust_4

Unpaid Losses and Loss Adjustment Expenses (Details 1) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Unpaid Losses and Loss Adjustment Expenses (Details)
Cmp Line Of Business	$ 81,303,803	$ 73,545,181
Other Liability Line Of Business	1,122,823	1,283,174
Other Line Of Business	66,048	65,154
Line Of Business	$ 82,492,674	$ 74,893,509
Cmp Percent Line Of Business	98.50%	98.20%
Other Liability Percent Line Of Business	1.40%	1.70%
Other Percent Line Of Business	0.10%	0.10%
Percent Line Of Business	100%	100%

Unpaid Losses and Loss Adjust_5

Unpaid Losses and Loss Adjustment Expenses (Details 2) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Unpaid Losses and Loss Adjustment Expenses (Details 2)
Reserve For Unpaid Losses And Loss Adjustment Expenses At Beginning Of Year - Net Of Reinsurance	$ 52,639,867	$ 40,340,625
Reserve For Unpaid Losses And Loss Adjustment Expenses At Ending Of Year - Net Of Reinsurance	55,376,631	52,639,867
Reinsurance Recoverable On Unpaid Losses And Loss Adjustment Expenses At End Of Year	27,116,043	22,253,642
Reserve For Unpaid Losses And Loss Adjustment Expenses At End Of Year Per Balance Sheet, Gross Of Reinsurance	82,492,674	74,893,509
Incurred Losses And Loss Adjustment Expenses
Provision For Insured Events Of Current Year	26,097,435	26,683,872
Provision For Insured Events Of Prior Years	(124,595)	7,959,048
Total Incurred Losses And Loss Adjustment Expenses	25,972,840	34,642,920
Paid Losses And Loss Adjustment Expenses
Losses And Loss Adjustment Expenses Attributable To Insured Events Of The Current Year	8,007,546	8,285,021
Losses And Loss Adjustment Expenses Attributable To Insured Events Of Prior Years	15,228,530	14,058,657
Total Payments	$ 23,236,076	$ 22,343,678

Unpaid Losses and Loss Adjust_6

Unpaid Losses and Loss Adjustment Expenses (Details 3)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)	Dec. 31, 2014 USD ($)	Dec. 31, 2013 USD ($)	Dec. 31, 2012 USD ($)
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 221,327,301	$ 218,410,701
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(31,515,059)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	167,383,131	167,214,395
Short-duration Insurance Contracts, Accident Year 2012
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	18,353,966	18,327,346	$ 18,355,031	$ 18,235,335	$ 17,914,837	$ 18,050,131	$ 18,344,175	$ 18,895,666	$ 19,532,022	$ 18,511,598
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	0
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 18,355,881	18,020,565	18,001,581	17,638,646	17,265,513	16,734,967	15,369,629	13,411,125	11,673,621	$ 6,719,982
Cumulative Number Of Reported Claims	967
Short-duration Insurance Contracts, Accident Year 2013
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 22,852,457	22,802,931	22,859,132	22,397,394	22,798,398	21,742,580	20,323,841	20,118,343	19,570,946
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(2)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 22,849,314	22,802,275	22,364,215	21,875,978	21,415,490	19,067,334	14,319,057	10,656,777	$ 7,594,731
Cumulative Number Of Reported Claims	850
Short-duration Insurance Contracts, Accident Year 2014
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 17,965,556	18,048,285	17,898,306	18,034,749	17,640,211	14,930,960	15,394,995	16,884,731
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(108,710)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 17,817,189	17,806,537	17,487,722	16,843,128	14,556,687	9,173,947	6,082,893	$ 3,826,263
Cumulative Number Of Reported Claims	760
Short-duration Insurance Contracts, Accident Year 2015
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 25,332,806	24,495,614	23,006,844	21,707,615	22,471,512	20,840,034	20,452,199
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(525,502)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 23,197,570	21,502,400	20,148,880	17,700,688	14,978,639	11,151,955	$ 6,263,796
Cumulative Number Of Reported Claims	749
Short-duration Insurance Contracts, Accident Year 2016
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 27,006,706	26,337,621	25,677,378	24,126,775	22,908,016	21,646,663
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(1,584,393)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 24,528,218	23,326,143	21,438,785	15,916,432	12,009,273	$ 7,435,120
Cumulative Number Of Reported Claims	808
Short-duration Insurance Contracts, Accident Year 2017
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 26,103,135	25,091,934	23,876,588	23,453,130	21,914,736
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(2,301,034)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 21,188,239	18,869,369	15,289,400	11,503,228	$ 6,405,641
Cumulative Number Of Reported Claims	825
Short-duration Insurance Contracts, Accident Year 2018
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 19,179,716	20,670,880	18,099,500	19,048,233
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(3,465,021)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 13,750,695	12,129,118	9,254,754	$ 4,959,689
Cumulative Number Of Reported Claims	614
Short-Duration Insurance Contract, Accident Year 2021 [Member]
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 23,198,334
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(11,452,987)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 5,027,785
Cumulative Number Of Reported Claims	626
Short-Duration Insurance Contract, Accident Year 2019 [Member]
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 18,723,515	19,182,851	17,349,941
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(5,558,880)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 10,898,586	7,603,418	$ 4,292,275
Cumulative Number Of Reported Claims	648
Short-Duration Insurance Contract, Accident Year 2020 [Member]
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 22,611,110	24,302,958
Total Of Incurred But Not Reported Liabilities Plus Expected Development On Reported Claims	(6,518,530)
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 9,769,654	$ 6,004,292
Cumulative Number Of Reported Claims	771

Unpaid Losses and Loss Adjust_7

Unpaid Losses and Loss Adjustment Expenses (Details 4) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Unpaid Losses and Loss Adjustment Expenses (Details 3)
Cumulative Incurred Losses And Alae	$ 221,327,301	$ 218,410,701
Less Cumulative Paid Losses And Alae	(167,383,131)	(167,214,395)
Reserve For Unpaid Losses And Alae (latest 10 Accident Years)	53,944,170	51,196,306
Reserves For Unpaid Losses And Alae (beyond Latest 10 Accident Years)	68,604	79,703
Reserves For Unpaid Unallocated Loss Adjustment Expenses	1,363,857	1,363,858
Reserve For Unpaid Losses And Loss Adjustment Expenses,net Of Reinsurance	55,376,631	52,639,867
Reinsurance Recoverable On Unpaid Losses And Loss Adjustment Expenses	27,116,043	22,253,642
Reserve For Unpaid Losses And Loss Adjustment Expenses, Gross Of Reinsurance	$ 82,492,674	$ 74,893,509

Unpaid Losses and Loss Adjust_8

Unpaid Losses and Loss Adjustment Expenses (Details Narrative)	12 Months Ended
	Dec. 31, 2021 USD ($)
Accumulated Other Comprehensive Income
Favorable Development	$ 124,595
Improvement Expense	8,083,643
Unfavourable Development Expense	$ 7,959,048

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Deferred Policy Acquisition Costs (Details)
Deferred Policy Acquisition Costs At Beginning Of Year	$ 3,503,248	$ 3,619,594
Policy Acquisition Costs Deferred During Year	2,926,203	4,782,461
Policy Acquisition Costs Amortized During Year	(5,442,645)	(4,898,807)
Allowance For Policy Acquisition Cost Estimated During The Year	(1,409,654)	0
Deferred Policy Acquisition Costs At End Of Year	$ 986,806	$ 3,503,248

Deferred Policy Acquisition C_4

Deferred Policy Acquisition Costs (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Deferred Policy Acquisition Costs (Details)
Allowance For Policy Acquisition Cost Estimated During The Year	$ 1,409,654	$ 0

Accrued Expenses and Other Li_2

Accrued Expenses and Other Liabilites (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Accrued Expenses and Other Liabilites (Details)
Premium Payable	$ 508,147	$ 393,466
Unearned Policy Fee Income	224,536	454,883
Retirement Plan	12,413	145,473
Accrued Salaries And Employee Benefits	53,449	973,504
Commission Payable	(251)	869
Security Deposit For Calabasas Building Sale	0	380,850
Other	1,467,943	1,228,405
Total Accrued Expenses And Other Liabilities	$ 2,266,237	$ 3,577,450

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative)	Dec. 31, 2021 USD ($)
Accrued Expenses and Other Liabilites (Details)
Losses and Loss Adjustment Expenses	$ 500,000

Reinsurance (Details)

Reinsurance (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Reinsurance (Details)
Direct Written	$ 32,871,625	$ 36,338,800
Reinsurance Assumed	3,395,010	304,030
Reinsurance Ceded	(11,551,580)	(8,078,748)
Net Written	24,715,055	28,564,082
Direct Earned	38,278,730	36,108,230
Reinsurance Assumed Premiums	1,844,931	156,639
Reinsurance Ceded Premiums	(11,693,756)	(8,096,701)
Net Premium Earned	28,429,905	28,168,168
Direct Incurred Loss And Loss Adjustment Expenses	35,218,127	48,971,172
Assumed Loss And Loss Adjustment Expenses	836,622	89,204
Ceded Loss And Loss Adjustment Expenses	(10,081,909)	(14,417,456)
Incurred Losses And Loss Adjustment Expenses	$ 25,972,840	$ 34,642,920
Percent Of Ceded Earned Premium To Direct Earned Premium	29%	22%

Reinsurance (Details 1)

Reinsurance (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Renaissance Reinsurance U.S., Inc.
A.m. Best Rating	A+	A+
Combined Retention	$ 500,000	$ 500,000
Hannover Rusk SE
A.m. Best Rating	A+	A+
Combined Retention	$ 500,000	$ 500,000

Reinsurance (Details Narrative)

Reinsurance (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Apr. 01, 2022	Mar. 31, 2022
Crusader's retention on losses	$ 5,000,000
First Layer participation percentage	0%	0%
First Layer Lower Limit	$ 500,000	$ 500,000
First Layer Upper Limit	$ 1,000,000	$ 1,000,000
Second Layer participation percentage	0%	0%
Second Layer Lower Limit	$ 1,000,000	$ 1,000,000
Second Layer Upper Limit	$ 4,000,000	$ 4,000,000
Clash layer participation percentage	0%	0%
Clash layer layer Lower Limit	$ 4,000,000	$ 4,000,000
Clash layer Upper Limit	8,000,000	8,000,000
Crusader's primary excess of losses	$ 500,000	$ 500,000
Increase in collateral percentage	150% to 325%
Reduction percentage in capital and policyholder surplus	10%
Unearned premium and loss reserves percentage	150%
First Layer Reinsurance Treaties	5%	5%
First Layer Lower Limit Reinsured Losses	$ 1,000,000	$ 1,000,000
First Layer Upper Limit Reinsured Losses	$ 10,000,000	$ 10,000,000
Second Layerreinsurance Treaties	0%	0%
Second Layer Lower Limit Reinsured Losses	$ 10,000,000	$ 10,000,000
Second Layer Upper Limit Reinsured Losses	46,000,000	46,000,000
Crusader's secondary excess of losses	$ 1,000,000	1,000,000
Description of facultative authorized reinsurance treaty	Unlike the excess of loss treaties which cover all risks underwritten by Crusader, the facultative reinsurance treaties cover specific risks for properties with total insured values in excess of $4,000,000, (the property coverage limit of the excess of loss treaties). In calendar year 2020 and during the first five months of 2021, the facultative reinsurance treaties provided coverage for reinsured losses between $4,000,000 and $8,000,000. From June 2021, the facultative reinsurance treaties had two sections which provide coverage for reinsured losses between $4,000,000 and $9,000,000 (Section A) and $4,000,000 and $15,000,000 (Section B) depending on location of the insured risk
Excess of loss reinsurance treaties reduced	$ 16,000,000
Excess of loss reinsurance treaties reduced with retention	$ 1,000,000
Excess of loss reinsurance treaties reduced with participation	0%
Available-for-sale, fair value	$ 72,413,405	83,409,694
Available-for-sale, amortized cost	71,218,405	80,071,280
Termination of Reinsurance Arrangement
Available-for-sale, fair value	8,243,758	824,500	$ 7,794,765	$ 7,944,916
Available-for-sale, amortized cost	$ 8,162,053	$ 787,653		$ 7,836,756

Profit Sharing Plan (Details)

Profit Sharing Plan (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Profit Sharing Plan (Details)
Profit Sharing Plan Expenses	$ 171,205	$ 154,331

Profit Sharing Plan (Details Na

Profit Sharing Plan (Details Narrative)	12 Months Ended
	Dec. 31, 2021
Profit Sharing Plan (Details)
Employer Matching Contribution, Percent of Match	4%

Statutory Capital and Surplus_2

Statutory Capital and Surplus (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statutory Capital and Surplus (Details)
Statutory Net Loss	$ (1,774,020)	$ (12,862,588)
Statutory Capital And Surplus	$ 22,494,454	$ 26,893,515

Statutory Capital and Surplus_3

Statutory Capital and Surplus (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Statutory Capital and Surplus (Details)
Cash Dividends	$ 0	$ 4,000,000
Crusaders Adjusted Capital	300%
Statutory Surplus	10%
Combined Loss Ratio	120%
Comprehensive Plan To Increase The Adjusted Capital	300%
Total Adjusted Capital	300%
Loss Ratio	130%

Stock Plans (Details)

Stock Plans (Details)	12 Months Ended
	Dec. 31, 2021 $ / shares
Stock Plans (Details)
Weighted-average Grant Date Fair Value	$ 4.52
Expected Dividend Yield	0%
Expected Volatility	96.35%
Risk-free Interest Rate	0.09%
Expected Term (years)	4 years
Expected Forfeiture	50%

Stock Plans (Details 1)

Stock Plans (Details 1)	12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares shares
Stock Plans (Details)
Outstanding, Beginning | shares	0
Non-qualified Stock Option Granted | shares	14,250
Restricted Stock Granted Granted | shares	17,000,000
Stock Options Forfeited Or Expired | shares	(61,000)
Stock Options Exercised | shares	0
Outstanding, Ending | shares	31,250
Exercisable, Ending | shares	0
Weighted-average Exercise Price Outstanding, Beginning	$ 0
Weighted-average Exercise Price Non-qualified Stock Option Granted	4.52
Weighted-average Exercise Price Restricted Stock Granted	4.52
Weighted-average Exercise Price Forfeited Or Expired	4.52
Weighted-average Exercise Price Exercised	0
Weighted-average Exercise Price Outstanding, Ending	4.52
Weighted-average Exercise Price Exercisable	$ 0
Weighted-average Remaining Contactual Life Outstanding, Beginning Balance	0 years
Weighted-average Remaining Contactual Life, Non-qualified Stock Option Granted	4 years
Weighted-average Remaining Contactual Life, Restricted Stock Granted	4 years
Weighted-average Remaining Contactual Life Outstanding, Ending Balance	3 years 9 months 14 days
Weighted-average Remaining Contactual Life Exercisable	0 years
Aggregate Intrinsic Value Outstanding, Beginning | $	$ 0
Aggregate Intrinsic Value, Forfeited Or Expired	$ 0
Aggregate Intrinsic Value Outstanding, Ending | $	$ 0
Aggregate Intrinsic Value Exercisable | $	$ 0

Stock Plans (Details Narrative)

Stock Plans (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	May 27, 2021
Stock-based Compensation Expense	$ 11,589	$ 0
Unrecognized Compensation Cost	$ 152,003
Weighted-average Exercise, In Years	3 years 8 months 26 days
Common Stock Available, Shares	500,000
Non-qualified Stock Options Description	The non-qualified stock options granted under the Plan in 2021 vest 25% on the first anniversary of the grant date and 25% annually thereafter on the anniversary date and expire four years after the date of the grant. The restricted stock grants granted under the Plan in 2021 vest 100% on the fourth anniversary of the grant date.
Restricted Stock Outstanding, Share	31,250	0
Equity Incentive Plan
Number of Shares Authorized			500,000
Non-qualified Stock Options Granted	44,250
Restricted Stock Grants	48,000
Non-qualified Stock Forfeited	30,000
Non-qualified Outstanding, Share	14,250
Restricted Stock Forfeited	31,000
Restricted Stock Outstanding, Share	17,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes (Details)
Deferred, Federal	$ 450,117	$ 3,566,840
Federal, Total	450,117	3,566,840
Current, State	8,800	8,800
Deferred, State	0	(28,042)
State, Total	8,800	(19,242)
Total, Current	8,800	8,800
Total, Deferred	450,117	3,538,798
Total tax expense	$ 458,917	$ 3,547,598

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Taxes (Details)
Federal Tax Rate	21%	21%
Computed income tax expense (benefit) at 21%	$ (1,095,010)	$ (3,768,138)
Tax effect of:
State tax expense (benefit), net of federal tax benefit	137,312	(572,511)
Change in valuation allowance - state net operating losses	(130,360)	557,310
Change in valuation allowance - federal	1,547,392	7,319,959
Other, including nondeductible expenses	3,620	10,920
Other - prior year true up	(4,037)	58
Income tax expense	$ 458,917	$ 3,547,598

Income Taxes (Details 2)

Income Taxes (Details 2) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred Tax Assets
Discounting Of Loss Reserves	$ 605,164	$ 531,845
Net Unearned Premium	599,571	759,659
Unearned Commission	0	438,574
Unearned Policy Fees	62,834	127,293
Net Operating Loss Caryforwards	8,584,487	7,769,603
State Income Taxes	2,509,115	2,402,438
Unrealized Losses On Investments	0	0
Bad Debt Reserve	62,673	333,649
Other Deferred Tax Assets	474,854	237,803
Total Deferred Tax Assets	12,898,698	12,600,864
Valuation Allowance	11,939,459	10,557,080
Deferred Tax Assets Net Of Valuation Allowance	959,239	2,043,784
Deferred Tax Liabilities
Policy Acquisition Costs	191,586	858,705
State Tax On Undistributed Insurance Company Earnings	25,357	84,219
Federal Tax Liability On State Deferred Tax Assets	63,456	91,277
Depreciation	302,073	266,880
Unrealized Gains On Investments	376,767	742,703
Total Deferred Tax Liabilities	959,239	2,043,784
Net Deferred Tax Assets	$ 0	$ 0

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Income Taxes (Details Narrative)
Deferred Tax Asset	$ 8,584,487
Federal Net Operating Loss Caryforwards Beginning To Expire In 2035	40,878,510
State Tax Loss Carryforwards Expiring Between 2028 And 2040	2,509,115
Deferred Tax Asset Valuation Allowance On Federal Tax Loss Carryforward	$ 11,939,459	$ 10,557,080
Federal Effected State Tax Rate	6.98%

Repurchase of Common Stock (Det

Repurchase of Common Stock (Details)	12 Months Ended
	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Summary of Significant Accounting Policies
Number Of Shares Repurchased, 2020 Program	22	857
Cost Of Shares Repurchased Allocated To Retained Earnings, 2020 Program	$ 91	$ 4,071
Allocated To Capital, 2020 Program	10	422
Total Cost Of Shares Repurchased	$ 101	$ 4,493
Number Of Shares Repurchased, 2008 Program	0	978
Cost Of Shares Repurchased Allocated To Retained Earnings, 2008 Program	$ 0	$ 5,760
Allocated To Capital, 2008 Program	0	480
Total Cost Of Shares Repurchasedl, 2008 Program	$ 0	$ 6,240

Repurchase of Common Stock (D_2

Repurchase of Common Stock (Details Narrative) - USD ($)	Dec. 31, 2020	Aug. 10, 2020	Dec. 19, 2008
Summary of Significant Accounting Policies
Dollar Amount Authorized Under 2020 Program		$ 5,000,000
Dollar Amount Available Under 2020 Program	$ 4,995,406
Common Stock, 2008 Program			500,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative)	12 Months Ended
	Dec. 31, 2021 USD ($) shares
Related Party Transactions (Details Narrative)
Consulting Services Contracted Amount | $	$ 20,000
Consulting Services Paid Amount | shares	15,000

Loss Per Share (Details)

Loss Per Share (Details)	3 Months Ended								12 Months Ended
	Dec. 31, 2021 USD ($) $ / shares	Sep. 30, 2021 USD ($) $ / shares	Jun. 30, 2021 USD ($) $ / shares	Mar. 31, 2021 USD ($) $ / shares	Dec. 31, 2020 USD ($) $ / shares	Sep. 30, 2020 USD ($) $ / shares	Jun. 30, 2020 USD ($) $ / shares	Mar. 31, 2020 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($) $ / shares shares
Per Share Amount - Basic | $ / shares	$ (0.76)	$ (0.47)	$ (0.27)	$ 0.43	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (1.07)	$ (4.05)
Net Loss | $	$ (4,023,945)	$ (2,510,198)	$ (1,406,811)	$ 2,267,703	$ (2,071,985)	$ (17,940,488)	$ (434,814)	$ (1,043,826)	$ (5,673,251)	$ (21,491,113)
Weighted Average Shares Outstanding Denominator - Basic | shares									530,487,200	530,582,900
Per Share Amount - Diluted | $ / shares	$ (1.07)	$ (0.47)	$ (0.27)	$ 0.43	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (1.07)	$ (4.05)
Weighted Average Shares Outstanding Denominator - Diluted | shares									5,304,872	5,305,829
Basic Loss Per Share [Member]
Per Share Amount - Basic | $ / shares									$ (1.07)	$ (4.05)
Net Loss | $									$ (5,673,251)	$ (21,491,113)
Weighted Average Shares Outstanding Denominator - Basic | shares									5,304,872	5,305,829
Diluted Loss Per Share[Member]
Net Loss | $									$ (5,673,251)	$ (21,491,113)
Per Share Amount - Diluted | $ / shares									$ (1.07)	$ (4.05)
Weighted Average Shares Outstanding									5,304,872	5,305,829
Effect Of Diluted Securities | $									$ 0	$ 0
Weighted Average Shares Outstanding Denominator - Diluted | shares									5,304,872	5,305,829

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Pre-Tax Amount [Member]
Accumulated other comprehensive income, Beginning balance	$ 3,338,414	$ 1,497,299
Changes in net unrealized gain on investments	(2,025,511)	1,905,367
Reclassification adjustment for net realized gains included in net loss	(117,903)	(642,524)
Accumulated other comprehensive income, Ending balance	1,195,000	3,338,413
Tax (Expense) Benefit [Member]
Accumulated other comprehensive income, Beginning balance	(701,067)	(314,433)
Changes in net unrealized gain on investments	425,357	(400,127)
Reclassification adjustment for net realized gains included in net loss	24,760	13,493
Accumulated other comprehensive income, Ending balance	(250,950)	(701,067)
Net-of-Tax Amount [Member]
Accumulated other comprehensive income, Beginning balance	2,637,347	1,182,866
Changes in net unrealized gain on investments	(1,600,154)	1,505,240
Reclassification adjustment for net realized gains included in net loss	(93,143)	(50,760)
Accumulated other comprehensive income, Ending balance	$ 944,050	$ 2,637,347

Subsequent Events (Details Narr

Subsequent Events (Details Narrative)			1 Months Ended
	Feb. 01, 2022 USD ($)	Sep. 10, 2021 USD ($)	Jan. 31, 2022 USD ($)	May 31, 2022 USD ($)	Mar. 31, 2022 USD ($)	Jan. 11, 2022 ft²	Sep. 30, 2021 USD ($)
Premium Trust Deficiency					$ 275,901		$ 2,452,835
Monthly Rental Payment		$ 20,000
Subsequent Event [Member]
Premium Trust Account Deficiency				$ 432,900
New Lease [Member] | Western General [Member] | Subsequent Event [Member]
Area Of Land | ft²						4,199
Monthly Rental Payment	$ 10,539
Initial Payment	20,539
Refundable Security Deposit	$ 10,000
Contributed Amount Book Value			$ 1,991,956

Selected Quarterly Financial _3

Selected Quarterly Financial Data (Unaudited) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Dec. 31, 2021	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Mar. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Selected Quarterly Financial Data (Unaudited) (Details)
Total Revenues	$ 8,188,477	$ 8,595,648	$ 8,132,605	$ 11,471,654	$ 8,319,017	$ 8,259,686	$ 7,976,227	$ 8,005,181	$ 36,388,384	$ 32,560,111
Income (loss) Before Taxes	(3,875,219)	(2,450,619)	(1,430,835)	(2,542,339)	(2,067,539)	(14,345,916)	(384,562)	(1,145,498)
Net Loss	$ (4,023,945)	$ (2,510,198)	$ (1,406,811)	$ 2,267,703	$ (2,071,985)	$ (17,940,488)	$ (434,814)	$ (1,043,826)	$ (5,673,251)	$ (21,491,113)
Per Share Amount - Basic	$ (0.76)	$ (0.47)	$ (0.27)	$ 0.43	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (1.07)	$ (4.05)
Per Share Amount - Diluted	$ (1.07)	$ (0.47)	$ (0.27)	$ 0.43	$ (0.39)	$ (3.38)	$ (0.08)	$ (0.20)	$ (1.07)	$ (4.05)

Supplementry Information on Los

Supplementry Information on Loss and Alae Development (Unaudited) (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 221,327,301	$ 218,410,701
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	167,383,131	167,214,395
Short-duration Insurance Contracts, Accident Year 2012
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	18,353,966	18,327,346	$ 18,355,031	$ 18,235,335	$ 17,914,837	$ 18,050,131	$ 18,344,175	$ 18,895,666	$ 19,532,022	$ 18,511,598
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	18,355,881	18,020,565	18,001,581	17,638,646	17,265,513	16,734,967	15,369,629	13,411,125	11,673,621	$ 6,719,982
Short-duration Insurance Contracts, Accident Year 2013
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	22,852,457	22,802,931	22,859,132	22,397,394	22,798,398	21,742,580	20,323,841	20,118,343	19,570,946
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	22,849,314	22,802,275	22,364,215	21,875,978	21,415,490	19,067,334	14,319,057	10,656,777	$ 7,594,731
Short-duration Insurance Contracts, Accident Year 2014
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	17,965,556	18,048,285	17,898,306	18,034,749	17,640,211	14,930,960	15,394,995	16,884,731
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	17,817,189	17,806,537	17,487,722	16,843,128	14,556,687	9,173,947	6,082,893	$ 3,826,263
Short-duration Insurance Contracts, Accident Year 2015
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	25,332,806	24,495,614	23,006,844	21,707,615	22,471,512	20,840,034	20,452,199
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	23,197,570	21,502,400	20,148,880	17,700,688	14,978,639	11,151,955	$ 6,263,796
Short-duration Insurance Contracts, Accident Year 2016
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	27,006,706	26,337,621	25,677,378	24,126,775	22,908,016	21,646,663
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	24,528,218	23,326,143	21,438,785	15,916,432	12,009,273	$ 7,435,120
Short-duration Insurance Contracts, Accident Year 2017
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	26,103,135	25,091,934	23,876,588	23,453,130	21,914,736
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	21,188,239	18,869,369	15,289,400	11,503,228	$ 6,405,641
Short-duration Insurance Contracts, Accident Year 2018
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	19,179,716	20,670,880	18,099,500	19,048,233
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	13,750,695	12,129,118	9,254,754	$ 4,959,689
Short-Duration Insurance Contract, Accident Year 2019 [Member]
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	18,723,515	19,182,851	17,349,941
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	10,898,586	7,603,418	$ 4,292,275
Short-Duration Insurance Contract, Accident Year 2020 [Member]
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	22,611,110	24,302,958
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	9,769,654	$ 6,004,292
Short-Duration Insurance Contract, Accident Year 2021 One [Member]
Cumulative Incurred Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	23,198,334
Cumulative Paid Losses And Allocated Loss Adjustment Expenses, Net Of Reinsurance	$ 5,027,785